Nutrien Reports First Quarter 2023 Results

 

Delivered second highest net earnings of any first quarter on record, advanced strategic initiatives and returned $1.1 billion to shareholders through dividends and share repurchases. Full-year guidance reflects expectation for fertilizer benchmark prices to stabilize near mid-cycle values.

 

All amounts are in US dollars except as otherwise noted

 

 Nutrien Ltd. (TSX and NYSE: NTR) announced today its first quarter 2023 results, with net earnings of $0.6 billion ($1.14 diluted net earnings per share). First quarter 2023 adjusted net earnings per share 1 was $1.11 and adjusted EBITDA 1 was $1.4 billion.

 

"Nutrien delivered adjusted EBITDA of $1.4 billion in the first quarter and continued to demonstrate the advantages of our flexible, low-cost production assets and global distribution network. We invested in initiatives to sustain and grow our asset base and returned $1.1 billion to shareholders during the quarter," commented Ken Seitz, Nutrien's President and CEO.

 

"Crop input demand has strengthened as the spring planting season progresses in the northern hemisphere and higher cost inventory is moving through the channel. We are encouraged by the continued stabilization of fertilizer markets following a year of unprecedented volatility and anticipate increased demand in the second half of 2023 due to strong agriculture fundamentals, improved grower affordability and lower inventory levels. With fertilizer prices near mid-cycle levels, we expect to generate strong operating cash flows in 2023 and to maintain a balanced and disciplined approach to capital allocation," added Mr. Seitz.

 

  Highlights 2 :  

 
  • Nutrien Ag Solutions ("Retail") adjusted EBITDA declined to $(34) million in the first quarter of 2023 primarily due to lower sales and gross margins for crop nutrients and crop protection products compared to the record levels achieved in 2022. Crop nutrient margins were below normalized levels in the first quarter as prices declined and we worked through higher cost inventory.
  •  
  • Potash adjusted EBITDA declined to $676 million in the first quarter of 2023 due to lower net realized selling prices and lower sales volumes. North American sales volumes were impacted by just-in-time buying. Lower offshore demand from customers in Asia was largely offset by record first quarter Canpotex sales volumes to Brazil.
  •  
  • Nitrogen adjusted EBITDA declined to $676 million in the first quarter of 2023 due to lower net realized selling prices for all major nitrogen products. This was partially offset by lower natural gas costs and increased operating rates at our North American nitrogen plants.
  •  
  • Nutrien repurchased 11.8 million shares year-to-date as of March 31, 2023, under its normal course issuer bid programs, for approximately $900 million. The Company's total shares outstanding declined to 496 million as at the end of the first quarter of 2023, representing a 10 percent reduction compared to the same period in 2022.
  •  
  • Nutrien full year 2023 adjusted EBITDA and adjusted net earnings per share guidance 1 was revised to $6.5 to $8.0 billion and $5.50 to $7.50 per share, respectively.
  •  
      
 

1.

 
  These (and any related guidance, if applicable) are non-IFRS financial measures. See the "Non-IFRS Financial Measures" section for further information.
 

2.

 
  Our discussion of highlights set out on this page is a comparison of the results for the three months ended March 31, 2023 to the results for the three months ended March 31, 2022, unless otherwise noted.
 

  Management's Discussion and Analysis  

 

The following management's discussion and analysis ("MD&A") is the responsibility of management and is dated as of May 10, 2023. The Board of Directors ("Board") of Nutrien carries out its responsibility for review of this disclosure principally through its Audit Committee, composed entirely of independent directors. The Audit Committee reviews and, prior to its publication, approves this disclosure pursuant to the authority delegated to it by the Board. The term "Nutrien" refers to Nutrien Ltd. and the terms "we", "us", "our", "Nutrien" and "the Company" refer to Nutrien and, as applicable, Nutrien and its direct and indirect subsidiaries on a consolidated basis. Additional information relating to Nutrien (which, except as otherwise noted, is not incorporated by reference herein), including our annual report dated February 16, 2023 ("2022 Annual Report"), which includes our annual audited consolidated financial statements and MD&A, and our annual information form dated February 16, 2023, each for the year ended December 31, 2022, can be found on SEDAR at www.sedar.com and on EDGAR at www.sec.gov . No update is provided to the disclosure in our 2022 annual MD&A except for material information since the date of our annual MD&A. The Company is a foreign private issuer under the rules and regulations of the US Securities and Exchange Commission (the "SEC").

 

This MD&A is based on and should be read in conjunction with the Company's unaudited interim condensed consolidated financial statements as at and for the three months ended March 31, 2023 ("interim financial statements") based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and prepared in accordance with International Accounting Standard ("IAS") 34 "Interim Financial Reporting", unless otherwise noted. This MD&A contains certain non-IFRS financial measures and ratios and forward-looking statements, which are described in the "Non-IFRS Financial Measures" and the "Forward-Looking Statements" sections, respectively.

 

  Market Outlook and Guidance  

 

  Agriculture and Retail  

 
  • Geopolitical and weather-related challenges continue to impact global agriculture commodity markets, including significant production and export reductions from Ukraine and severe drought conditions in Argentina. The global grain stocks-to-use ratio is projected to end the current growing season at the lowest level in over 25 years. Corn, soybeans and wheat prices have softened recently due to seasonal pressure resulting from the expectation of higher Brazilian and US crop production. However, new crop futures are still approximately 15 percent above the 10-year average and grower margins remain healthy, providing incentive to invest in their crop and boost production.
  •  
  • We expect an 8 million acre increase in US major crop planted area in 2023, including an additional 3 million acres of corn, which is supportive of crop input demand. Planting activity is progressing well in North America and fertilizer application rates have been in line with historical average levels and well above rates in the spring of 2022. The combination of strong demand and logistical challenges has tightened North American fertilizer supply.
  •  
  • South American crop production has been mixed as record Brazilian soybean production and strong prospects for the safrinha corn crop are balanced against the impacts of severe drought in Argentina. We expect increased application rates for the 2023 summer crop planting season due to improved affordability ratios compared to the previous year. Australian winter crop planting is progressing well, with no major shifts in acreage expected from record 2022 levels.
  •  

  Crop Nutrient Markets  

 
  • Potash demand has strengthened in North America as the spring application season has progressed, while engagement in offshore markets has been more variable. We anticipate increased global potash demand in the second half of 2023 as a result of lower expected inventories and improved grower affordability compared to 2022.
  •  
  • Potash shipments from Belarus are projected to be above our previous expectation for 2023, partially offset by lower expected exports from Russia. We now project Belarusian shipments will be down 25 to 40 percent this year and Russian shipments down 25 to 35 percent compared to 2021. We have maintained our global potash shipment forecast between 63 and 67 million tonnes in 2023.
  •  
  • North American nitrogen supply has tightened during the spring season due to strong demand and lower net imports. Global nitrogen trade has been impacted by weaker industrial demand in Asia and Europe, and lower Indian urea imports. We expect ammonia markets will strengthen as demand increases and supply remains challenged with approximately 40 percent of European capacity currently curtailed and Russian ammonia exports are constrained.
  •  
  • North American dry phosphate prices firmed during the spring season driven by tight supplies and strong demand, while international prices have remained relatively stable, supported by demand in Brazil and India. Lower ammonia and sulfur prices have been supportive of margins. We expect Chinese phosphate exports to increase moderately year-over-year due to expected loosening of government restrictions.
  •  

  Financial Guidance  

 
  • Based on market factors detailed above, we are revising full-year 2023 adjusted EBITDA guidance 2 to $6.5 to $8.0 billion and full year 2023 adjusted net earnings guidance 2 to $5.50 to $7.50 per share. We now project cash from operations of $5.0 to $5.8 billion, which is expected to be relatively stable due to an anticipated release in working capital.
  •  
  • Retail adjusted EBITDA guidance was lowered primarily due to the expectation of below normal crop nutrient gross margins in the first half of 2023 as we work through higher cost inventory.
  •  
  • Potash adjusted EBITDA guidance decreased due to lower forecasted benchmark fertilizer prices and sales tonnes. Potash sales tonnes guidance of 13.5 to 14.3 million tonnes assumes increased demand year-over-year in our key markets of North America and Brazil, partially offset by lower shipments to China due to delayed contract negotiations with Canpotex.
  •  
  • Nitrogen adjusted EBITDA guidance decreased due to lower forecasted benchmark fertilizer prices, partially offset by the expectation for lower North American natural gas prices.
  •  

All guidance numbers, including those noted above are outlined in the table below. Refer to page 56 of Nutrien's 2022 Annual Report for related assumptions and sensitivities, except as set forth below.

 
                                                                                                  
 

 

 
 

  Guidance Ranges 1 as of  

 
 

 

 
 

  May 10, 2023  

 
 

 

 
 

Feb 15, 2023

 
 

(billions of US dollars, except as otherwise noted)

 
 

  Low  

 
 

 

 
 

  High  

 
 

 

 
 

Low

 
 

 

 
 

High

 
 

Adjusted net earnings per share (in US dollars) 2,3

 
 

  5.50  

 
 

 

 
 

  7.50  

 
 

 

 
 

8.45

 
 

 

 
 

10.65

 
 

Adjusted EBITDA 2

 
 

  6.5  

 
 

 

 
 

  8.0  

 
 

 

 
 

8.4

 
 

 

 
 

10.0

 
 

Retail adjusted EBITDA

 
 

  1.60  

 
 

 

 
 

  1.75  

 
 

 

 
 

1.85

 
 

 

 
 

2.05

 
 

Potash adjusted EBITDA

 
 

  2.65  

 
 

 

 
 

  3.35  

 
 

 

 
 

3.7

 
 

 

 
 

4.5

 
 

Nitrogen adjusted EBITDA

 
 

  1.95  

 
 

 

 
 

  2.55  

 
 

 

 
 

2.5

 
 

 

 
 

3.2

 
 

Phosphate adjusted EBITDA (in millions of US dollars)

 
 

  550  

 
 

 

 
 

  700  

 
 

 

 
 

550

 
 

 

 
 

750

 
 

Potash sales tonnes (millions) 4

 
 

  13.5  

 
 

 

 
 

  14.3  

 
 

 

 
 

13.8

 
 

 

 
 

14.6

 
 

Nitrogen sales tonnes (millions) 4

 
 

  10.8  

 
 

 

 
 

  11.4  

 
 

 

 
 

10.8

 
 

 

 
 

11.4

 
 

Depreciation and amortization

 
 

  2.1  

 
 

 

 
 

  2.2  

 
 

 

 
 

2.1

 
 

 

 
 

2.2

 
 

Effective tax rate on adjusted earnings (%)

 
 

  23.5  

 
 

 

 
 

  24.0  

 
 

 

 
 

23.5

 
 

 

 
 

24.5

 
 

1 See the "Forward-Looking Statements" section.

 
 

2 These are non-IFRS financial measures. See the "Non-IFRS Financial Measures" section.

 
 

3 Assumes 499 million shares outstanding for May 10, 2023 adjusted net EPS guidance.

 
 

4 Manufactured product only. Nitrogen sales tonnes includes ESN® products.

 
 

  Consolidated Results  

 
                                                                                  
 

 

 
 

  Three Months Ended March 31  

 
 

(millions of US dollars, except as otherwise noted)

 
 

  2023  

 
 

 

 
 

2022

 
 

 

 
 

% Change

 
 

Sales

 
 

  6,107  

 
 

 

 
 

7,657

 
 

 

 
 

(20)

 
 

Freight, transportation and distribution

 
 

  199  

 
 

 

 
 

203

 
 

 

 
 

(2)

 
 

Cost of goods sold

 
 

  3,995  

 
 

 

 
 

4,197

 
 

 

 
 

(5)

 
 

Gross margin

 
 

  1,913  

 
 

 

 
 

3,257

 
 

 

 
 

(41)

 
 

Expenses

 
 

  974  

 
 

 

 
 

1,258

 
 

 

 
 

(23)

 
 

Net earnings

 
 

  576  

 
 

 

 
 

1,385

 
 

 

 
 

(58)

 
 

Adjusted EBITDA 1

 
 

  1,421  

 
 

 

 
 

2,615

 
 

 

 
 

(46)

 
 

Diluted net earnings per share

 
 

  1.14  

 
 

 

 
 

2.49

 
 

 

 
 

(54)

 
 

Adjusted net earnings per share 1

 
 

  1.11  

 
 

 

 
 

2.70

 
 

 

 
 

(59)

 
 

Cash used in operating activities

 
 

  (858)  

 
 

 

 
 

(62)

 
 

 

 
 

n/m

 
 

Cash used in investing activities

 
 

  (694)  

 
 

 

 
 

(457)

 
 

 

 
 

52

 
 

Cash used for dividends and share repurchases 2

 
 

  (1,143)  

 
 

 

 
 

(899)

 
 

 

 
 

27

 
 

1 These are non-IFRS financial measures. See the "Non-IFRS Financial Measures" section.

 
 

2 This is a supplementary financial measure. See the "Other Financial Measures" section.

 
 

Net earnings and adjusted EBITDA decreased in the first quarter of 2023 compared to the same period in 2022, due to lower net realized selling prices in all segments and lower sales volumes in Retail, Potash and Phosphate. This was partially offset by decreased cost of goods sold from lower natural gas costs and increased operating rates at our North American nitrogen plants. The increase in cash used in operating activities was primarily due to lower earnings across all segments. The increase in cash used in investing activities reflects higher capital expenditures to sustain and grow our asset base and incremental cash used for Retail business acquisitions. Cash used for dividends and share repurchases increased in the first quarter of 2023 compared to the same period in 2022 due to higher share repurchases under our normal course issuer bid programs.

 

  Segment Results  

 

Our discussion of segment results set out on the following pages is a comparison of the results for the three months ended March 31, 2023 to the results for the three months ended March 31, 2022, unless otherwise noted.

 

  Nutrien Ag Solutions ("Retail")  

 
                                                                                                                                                                                                                                                                                                           
 

 

 
 

  Three Months Ended March 31  

 
 

(millions of US dollars, except

 
 

  Dollars  

 
 

 

 
 

  Gross Margin  

 
 

 

 
 

  Gross Margin (%)  

 
 

as otherwise noted)

 
 

  2023  

 
 

 

 
 

2022

 
 

 

 
 

% Change

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

 

 
 

% Change

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

Sales

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Crop nutrients

 
 

  1,335  

 
 

 

 
 

1,587

 
 

 

 
 

(16)

 
 

 

 
 

  141  

 
 

 

 
 

292

 
 

 

 
 

(52)

 
 

 

 
 

  11  

 
 

 

 
 

18

 
 

Crop protection products

 
 

  1,154  

 
 

 

 
 

1,387

 
 

 

 
 

(17)

 
 

 

 
 

  208  

 
 

 

 
 

282

 
 

 

 
 

(26)

 
 

 

 
 

  18  

 
 

 

 
 

20

 
 

Seed

 
 

  507  

 
 

 

 
 

458

 
 

 

 
 

11

 
 

 

 
 

  72  

 
 

 

 
 

66

 
 

 

 
 

9

 
 

 

 
 

  14  

 
 

 

 
 

14

 
 

Merchandise

 
 

  246  

 
 

 

 
 

234

 
 

 

 
 

5

 
 

 

 
 

  44  

 
 

 

 
 

41

 
 

 

 
 

7

 
 

 

 
 

  18  

 
 

 

 
 

18

 
 

Nutrien Financial

 
 

  57  

 
 

 

 
 

49

 
 

 

 
 

16

 
 

 

 
 

  57  

 
 

 

 
 

49

 
 

 

 
 

16

 
 

 

 
 

  100  

 
 

 

 
 

100

 
 

Services and other

 
 

  148  

 
 

 

 
 

175

 
 

 

 
 

(15)

 
 

 

 
 

  118  

 
 

 

 
 

144

 
 

 

 
 

(18)

 
 

 

 
 

  80  

 
 

 

 
 

82

 
 

Nutrien Financial elimination 1

 
 

  (25)  

 
 

 

 
 

(29)

 
 

 

 
 

(14)

 
 

 

 
 

  (25)  

 
 

 

 
 

(29)

 
 

 

 
 

(14)

 
 

 

 
 

  100  

 
 

 

 
 

100

 
 

 

 
 

  3,422  

 
 

 

 
 

3,861

 
 

 

 
 

(11)

 
 

 

 
 

  615  

 
 

 

 
 

845

 
 

 

 
 

(27)

 
 

 

 
 

  18  

 
 

 

 
 

22

 
 

Cost of goods sold

 
 

  2,807  

 
 

 

 
 

3,016

 
 

 

 
 

(7)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Gross margin

 
 

  615  

 
 

 

 
 

845

 
 

 

 
 

(27)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Expenses ²

 
 

  830  

 
 

 

 
 

755

 
 

 

 
 

10

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

(Loss) earnings before finance costs and taxes ("EBIT")

 
 

  (215)  

 
 

 

 
 

90

 
 

 

 
 

n/m

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Depreciation and amortization

 
 

  181  

 
 

 

 
 

169

 
 

 

 
 

7

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

EBITDA

 
 

  (34)  

 
 

 

 
 

259

 
 

 

 
 

n/m

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Adjustments 3

 
 

  

 
 

 

 
 

(19)

 
 

 

 
 

(100)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Adjusted EBITDA

 
 

  (34)  

 
 

 

 
 

240

 
 

 

 
 

n/m

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

1 Represents elimination for the interest and service fees charged by Nutrien Financial to Retail branches.

 
 

2 Includes selling expenses of $765 million (2022 – $722 million).

 
 

3 See Note 2 to the interim financial statements.

 
 
  •   Retail adjusted EBITDA declined primarily due to lower sales and gross margins for crop nutrients and crop protection products compared to the record levels achieved in 2022. Expenses increased primarily due to higher selling expenses resulting from acquisitions completed in 2022 and general inflation. We achieved growth in our high-value proprietary products portfolio in both crop nutritionals and seed. We completed eight acquisitions and focused on the integration of acquisitions completed in 2022.
  •  
  •   Crop nutrients sales decreased primarily due to lower selling prices compared to the exceptionally strong comparable period in 2022. Gross margin per tonne decreased in all regions due to lower selling prices and higher cost inventory, partially offset by growth in proprietary nutritional products. Sales volumes decreased due to delayed grower purchases compared to the prior year and import restrictions in Argentina.
  •  
  •   Crop protection products sales and gross margin decreased, particularly in North America, attributable to a historically strong comparable period in 2022. Lower prices for certain herbicide products also led to reduced margins.
  •  
  •   Seed sales and gross margin increased due to strong corn sales in the southern US and higher proprietary seed margins. Australia experienced higher canola sales due to earlier supply availability.
  •  

  Potash  

 
                                                                                                                                                                                                                           
 

 

 
 

  Three Months Ended March 31  

 
 

(millions of US dollars, except

 
 

  Dollars  

 
 

 

 
 

  Tonnes (thousands)  

 
 

 

 
 

  Average per Tonne  

 
 

as otherwise noted)

 
 

  2023  

 
 

 

 
 

2022

 
 

% Change

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

% Change

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

% Change

 
 

Manufactured product

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Net sales

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

North America

 
 

  343  

 
 

 

 
 

833

 
 

 

 
 

(59)

 
 

 

 
 

  854  

 
 

 

 
 

1,218

 
 

 

 
 

(30)

 
 

 

 
 

  401  

 
 

 

 
 

684

 
 

 

 
 

(41)

 
 

Offshore

 
 

  659  

 
 

 

 
 

1,017

 
 

 

 
 

(35)

 
 

 

 
 

  1,782  

 
 

 

 
 

1,825

 
 

 

 
 

(2)

 
 

 

 
 

  370  

 
 

 

 
 

557

 
 

 

 
 

(34)

 
 

 

 
 

  1,002  

 
 

 

 
 

1,850

 
 

 

 
 

(46)

 
 

 

 
 

  2,636  

 
 

 

 
 

3,043

 
 

 

 
 

(13)

 
 

 

 
 

  380  

 
 

 

 
 

608

 
 

 

 
 

(38)

 
 

Cost of goods sold

 
 

  305  

 
 

 

 
 

305

 
 

 

 
 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  115  

 
 

 

 
 

100

 
 

 

 
 

15

 
 

Gross margin – total

 
 

  697  

 
 

 

 
 

1,545

 
 

 

 
 

(55)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  265  

 
 

 

 
 

508

 
 

 

 
 

(48)

 
 

Expenses ¹

 
 

  118  

 
 

 

 
 

251

 
 

 

 
 

(53)

 
 

 

 
 

Depreciation and amortization

 
 

 

 
 

  37  

 
 

 

 
 

37

 
 

 

 
 

 
 

EBIT

 
 

  579  

 
 

 

 
 

1,294

 
 

 

 
 

(55)

 
 

 

 
 

Gross margin excluding depreciation

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Depreciation and amortization

 
 

  97  

 
 

 

 
 

112

 
 

 

 
 

(13)

 
 

 

 
 

and amortization – manufactured 2

 
 

  302  

 
 

 

 
 

545

 
 

 

 
 

(45)

 
 

EBITDA/ Adjusted EBITDA

 
 

  676  

 
 

 

 
 

1,406

 
 

 

 
 

(52)

 
 

 

 
 

Potash controllable cash cost of

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

product manufactured 2

 
 

 

 
 

  62  

 
 

 

 
 

50

 
 

 

 
 

24

 
 

1 Includes provincial mining taxes of $119 million (2022 – $249 million).

 
 

2 These are non-IFRS financial measures. See the "Non-IFRS Financial Measures" section.

 
 
  •   Potash adjusted EBITDA declined due to lower net realized selling prices and lower sales volumes. We adjusted operating rates across our six-mine network in response to lower near-term demand and brought forward maintenance activities, preserving flexibility to increase production as demand increases.
  •  
  •   Sales volumes decreased   in North America primarily due to just-in-time buying. Lower offshore demand from customers in Asia was largely offset by record first quarter Canpotex sales volumes to Brazil.
  •  
  •   Net realized selling price decreased due to a decline in benchmark prices compared to the historically strong period in 2022.
  •  
  •   Cost of goods sold per tonne increased primarily due to lower production volumes and a pull forward of maintenance activities.
  •  

  Canpotex Sales by Market  

 
                                                  
 

 

 
 

  Three Months Ended March 31  

 
 

(percentage of sales volumes, except as otherwise noted)

 
 

  2023  

 
  

2022

 
  

Change

 
 

Other Asian markets 1

 
 

  38  

 
  

45

 
  

(7)

 
 

Latin America

 
 

  35  

 
  

32

 
  

3

 
 

Other markets

 
 

  13  

 
  

9

 
  

4

 
 

China

 
 

  12  

 
  

13

 
  

(1)

 
 

India

 
 

  2  

 
  

1

 
  

1

 
 

 

 
 

  100  

 
  

100

 
  

 

 
 

1 All Asian markets except China and India.

 
 

 

 
  

 

 
  

 

 
 

  Nitrogen  

 
                                                                                                                                                                                                                                                                 
 

 

 
 

  Three Months Ended March 31  

 
 

(millions of US dollars, except

 
 

  Dollars  

 
 

 

 
 

  Tonnes (thousands)  

 
 

 

 
 

  Average per Tonne  

 
 

as otherwise noted)

 
 

  2023  

 
 

 

 
 

2022

 
 

% Change

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

% Change

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

% Change

 
 

Manufactured product

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Net sales

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Ammonia

 
 

  385  

 
 

 

 
 

560

 
 

 

 
 

(31)

 
 

 

 
 

  534  

 
 

 

 
 

595

 
 

 

 
 

(10)

 
 

 

 
 

  721  

 
 

 

 
 

940

 
 

 

 
 

(23)

 
 

Urea and ESN ® 1

 
 

  461  

 
 

 

 
 

515

 
 

 

 
 

(10)

 
 

 

 
 

  747  

 
 

 

 
 

651

 
 

 

 
 

15

 
 

 

 
 

  617  

 
 

 

 
 

792

 
 

 

 
 

(22)

 
 

Solutions, nitrates and sulfates

 
 

  333  

 
 

 

 
 

439

 
 

 

 
 

(24)

 
 

 

 
 

  1,076  

 
 

 

 
 

1,079

 
 

 

 
 

 
 

 

 
 

  310  

 
 

 

 
 

407

 
 

 

 
 

(24)

 
 

 

 
 

  1,179  

 
 

 

 
 

1,514

 
 

 

 
 

(22)

 
 

 

 
 

  2,357  

 
 

 

 
 

2,325

 
 

 

 
 

1

 
 

 

 
 

  500  

 
 

 

 
 

651

 
 

 

 
 

(23)

 
 

Cost of goods sold 1

 
 

  648  

 
 

 

 
 

672

 
 

 

 
 

(4)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  275  

 
 

 

 
 

290

 
 

 

 
 

(5)

 
 

Gross margin – manufactured

 
 

  531  

 
 

 

 
 

842

 
 

 

 
 

(37)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  225  

 
 

 

 
 

361

 
 

 

 
 

(38)

 
 

Gross margin – other 1,2

 
 

  10  

 
 

 

 
 

18

 
 

 

 
 

(44)

 
 

 

 
 

Depreciation and amortization 1

 
 

 

 
 

  57  

 
 

 

 
 

53

 
 

 

 
 

7

 
 

Gross margin – total

 
 

  541  

 
 

 

 
 

860

 
 

 

 
 

(37)

 
 

 

 
 

Gross margin excluding depreciation

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

(Income) expenses ³

 
 

  (1)  

 
 

 

 
 

(12)

 
 

 

 
 

(92)

 
 

 

 
 

and amortization – manufactured 4

 
 

  282  

 
 

 

 
 

414

 
 

 

 
 

(32)

 
 

EBIT

 
 

  542  

 
 

 

 
 

872

 
 

 

 
 

(38)

 
 

 

 
 

Ammonia controllable cash cost of

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Depreciation and amortization

 
 

  134  

 
 

 

 
 

123

 
 

 

 
 

9

 
 

 

 
 

product manufactured 4

 
 

 

 
 

  63  

 
 

 

 
 

56

 
 

 

 
 

13

 
 

EBITDA/ Adjusted EBITDA

 
 

  676  

 
 

 

 
 

995

 
 

 

 
 

(32)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

1 Certain immaterial 2022 figures have been reclassified.

 
 

2 Includes other nitrogen and purchased products and comprises net sales of $133 million (2022 – $227 million) less cost of goods sold of $123 million (2022 – $209 million).

 
 

3 Includes earnings from equity-accounted investees of $30 million (2022 – $37 million).

 
 

4 These are non-IFRS financial measures. See the "Non-IFRS Financial Measures" section.

 
 
  •   Nitrogen adjusted EBITDA declined due to lower net realized selling prices for all major nitrogen products. During the quarter our ammonia utilization rate increased to 95 percent 1 , due in part to the continued focus on reliability initiatives and investments in our assets. We progressed our inflight brownfield expansions and advanced front-end engineering work on our proposed Geismar clean ammonia plant.
  •  
  •   Sales volumes were slightly higher as we benefited from increased production of urea and ESN ® at our Canadian nitrogen facilities, which offset lower ammonia production in Trinidad caused by natural gas curtailments.
  •  
  •   Net realized selling price was lower for all major nitrogen products due to weaker benchmark prices resulting from lower energy prices in key nitrogen producing regions and a temporary reduction in demand.
  •  
  •   Cost of goods sold per tonne decreased primarily due to lower natural gas costs. Ammonia   controllable cash cost of product manufactured increased mainly due to higher inputs costs, including materials and electricity.
  •  

  Natural Gas Prices in Cost of Production  

 
                                            
 

 

 
 

  Three Months Ended March 31  

 
 

(US dollars per MMBtu, except as otherwise noted)

 
 

  2023  

 
 

 

 
 

2022

 
 

 

 
 

% Change

 
 

Overall gas cost excluding realized derivative impact

 
 

  4.85  

 
 

 

 
 

6.86

 
 

 

 
 

(29)

 
 

Realized derivative impact

 
 

  

 
 

 

 
 

(0.01)

 
 

 

 
 

(100)

 
 

Overall gas cost

 
 

  4.85  

 
 

 

 
 

6.85

 
 

 

 
 

(29)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Average NYMEX

 
 

  3.42  

 
 

 

 
 

4.95

 
 

 

 
 

(31)

 
 

Average AECO

 
 

  3.21  

 
 

 

 
 

3.61

 
 

 

 
 

(11)

 
 
  •   Natural gas prices   in our cost of production decreased in the first quarter as a result of lower North American gas index prices and decreased gas costs in Trinidad, where our gas prices are linked to ammonia benchmark prices.
  •  

1 Excludes Trinidad and Joffre.

 

  Phosphate  

 
                                                                                                                                                                                                                                                     
 

 

 
 

  Three Months Ended March 31  

 
 

(millions of US dollars, except

 
 

  Dollars  

 
 

 

 
 

  Tonnes (thousands)  

 
 

 

 
 

  Average per Tonne  

 
 

as otherwise noted)

 
 

  2023  

 
 

 

 
 

2022

 
 

% Change

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

% Change

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

% Change

 
 

Manufactured product

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Net sales

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Fertilizer

 
 

  264  

 
 

 

 
 

393

 
 

 

 
 

(33)

 
 

 

 
 

  388  

 
 

 

 
 

460

 
 

 

 
 

(16)

 
 

 

 
 

  682  

 
 

 

 
 

854

 
 

 

 
 

(20)

 
 

Industrial and feed

 
 

  182  

 
 

 

 
 

170

 
 

 

 
 

7

 
 

 

 
 

  160  

 
 

 

 
 

191

 
 

 

 
 

(16)

 
 

 

 
 

  1,136  

 
 

 

 
 

891

 
 

 

 
 

27

 
 

 

 
 

  446  

 
 

 

 
 

563

 
 

 

 
 

(21)

 
 

 

 
 

  548  

 
 

 

 
 

651

 
 

 

 
 

(16)

 
 

 

 
 

  814  

 
 

 

 
 

865

 
 

 

 
 

(6)

 
 

Cost of goods sold

 
 

  357  

 
 

 

 
 

360

 
 

 

 
 

(1)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  651  

 
 

 

 
 

552

 
 

 

 
 

18

 
 

Gross margin - manufactured

 
 

  89  

 
 

 

 
 

203

 
 

 

 
 

(56)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  163  

 
 

 

 
 

313

 
 

 

 
 

(48)

 
 

Gross margin – other 1

 
 

  (2)  

 
 

 

 
 

4

 
 

 

 
 

n/m

 
 

 

 
 

Depreciation and amortization

 
 

 

 
 

  122  

 
 

 

 
 

63

 
 

 

 
 

94

 
 

Gross margin – total

 
 

  87  

 
 

 

 
 

207

 
 

 

 
 

(58)

 
 

 

 
 

Gross margin excluding depreciation

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Expenses

 
 

  17  

 
 

 

 
 

9

 
 

 

 
 

89

 
 

 

 
 

and amortization – manufactured 2

 
 

  285  

 
 

 

 
 

376

 
 

 

 
 

(24)

 
 

EBIT

 
 

  70  

 
 

 

 
 

198

 
 

 

 
 

(65)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Depreciation and amortization

 
 

  67  

 
 

 

 
 

41

 
 

 

 
 

63

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

EBITDA/ Adjusted EBITDA

 
 

  137  

 
 

 

 
 

239

 
 

 

 
 

(43)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

1 Includes other phosphate and purchased products and comprises net sales of $68 million (2022 – $72 million) less cost of goods sold of $70 million (2022 – $68 million).

 
 

2 This is a non-IFRS financial measure. See the "Non-IFRS Financial Measures" section.

 
 
  •   Phosphate adjusted EBITDA decreased due to lower sales volumes and lower net realized prices for fertilizer products. We completed several maintenance and reliability initiatives in the first quarter and expect operating rates to increase in the second half of 2023 following the completion of planned turnarounds in the second quarter.
  •  
  •   Sales volumes decreased due to lower production volumes and cautious buying activity.
  •  
  •   Net realized selling price decreased overall as lower fertilizer net realized selling prices were partially offset by higher industrial and feed net realized selling prices.
  •  
  •   Cost of goods sold per tonne increased due to higher depreciation from impairment reversals in 2022, and lower production, partially offset by lower ammonia and sulfur costs.
  •  

  Corporate and Others  

 
                                                               
 

 

 
 

  Three Months Ended March 31  

 
 

(millions of US dollars, except as otherwise noted)

 
 

  2023  

 
 

 

 
 

2022

 
 

 

 
 

% Change

 
 

Selling expenses

 
 

  (2)  

 
 

 

 
 

(2)

 
 

 

 
 

 
 

General and administrative expenses

 
 

  84  

 
 

 

 
 

70

 
 

 

 
 

20

 
 

Share-based compensation expense

 
 

  15  

 
 

 

 
 

135

 
 

 

 
 

(89)

 
 

Other (income) expenses

 
 

  (81)  

 
 

 

 
 

53

 
 

 

 
 

n/m

 
 

EBIT

 
 

  (16)  

 
 

 

 
 

(256)

 
 

 

 
 

(94)

 
 

Depreciation and amortization

 
 

  17  

 
 

 

 
 

16

 
 

 

 
 

6

 
 

EBITDA

 
 

  1  

 
 

 

 
 

(240)

 
 

 

 
 

n/m

 
 

Adjustments 1

 
 

  (14)  

 
 

 

 
 

174

 
 

 

 
 

n/m

 
 

Adjusted EBITDA

 
 

  (13)  

 
 

 

 
 

(66)

 
 

 

 
 

(80)

 
 

1 See Note 2 to the interim financial statements.

 
 
  •   Share-based compensation expense was lower due to a decrease in the fair value of share-based awards.
  •  
  •   Other (income) expenses of $(81) million was mainly due to an $80 million gain on amendments to our other post-retirement benefit plans, which resulted from design plan changes. In addition, we had net foreign exchange gains in 2023 compared to losses in 2022 mainly due to hedging activities related to our international operations, primarily for Brazil.
  •  

  Eliminations  

 
  • Eliminations are not part of the Corporate and Others segment. Eliminations of gross margin between operating segments were $(27) million for the first quarter of 2023 compared to $(200) million in the same period of 2022. We had significant eliminations in the first quarter of 2022 due to higher-margin inventories held by our Retail segment as global commodity benchmark prices increased.
  •  

  Finance Costs, Income Taxes and Other Comprehensive Income  

 
                          
 

 

 
 

  Three Months Ended March 31  

 
 

(millions of US dollars, except as otherwise noted)

 
 

  2023  

 
 

 

 
 

2022

 
 

 

 
 

% Change

 
 

Finance costs

 
 

  170  

 
 

 

 
 

109

 
 

 

 
 

56

 
 

Income tax expense

 
 

  193  

 
 

 

 
 

505

 
 

 

 
 

(62)

 
 

Other comprehensive income

 
 

  2  

 
 

 

 
 

176

 
 

 

 
 

(99)

 
 
  •   Finance costs were higher in the first quarter of 2023 compared to the same period in 2022 mainly due to higher interest on short-term debt from increased commercial paper interest rates and a higher average balance borrowed under our credit facilities.
  •  
  •   Income tax expense was lower in the first quarter of 2023 as a result of lower earnings compared to the same period in 2022. The change in the actual effective tax rate on ordinary earnings was a result of decreased earnings in higher tax jurisdictions.
  •  
  •   Other comprehensive income was lower primarily driven by changes in the currency translation of our foreign operations. In the first quarter of 2023, we had lower gains on foreign currency translation of our Retail foreign operations, as the Australian currency depreciated and the Brazilian currency had lower appreciation relative to the US dollar, compared to the same period in 2022.
  •  

  Liquidity and Capital Resources  

 

  Sources and Uses of Liquidity  

 

We continued to manage our capital in accordance with our capital allocation strategy. We believe that our internally generated cash flow, supplemented by available borrowings under new or existing financing sources, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements for the foreseeable future. Refer to the "Capital Structure and Management" section for details on our existing long-term debt and credit facilities.

 

  Sources and Uses of Cash  

 
                                      
 

 

 
 

  Three Months Ended March 31  

 
 

(millions of US dollars, except as otherwise noted)

 
 

  2023  

 
 

 

 
 

2022

 
 

 

 
 

% Change

 
 

Cash used in operating activities

 
 

  (858)  

 
 

 

 
 

(62)

 
 

 

 
 

n/m

 
 

Cash used in investing activities

 
 

  (694)  

 
 

 

 
 

(457)

 
 

 

 
 

52

 
 

Cash provided by financing activities

 
 

  2,129  

 
 

 

 
 

588

 
 

 

 
 

262

 
 

Effect of exchange rate changes on cash and cash equivalents

 
 

  (5)  

 
 

 

 
 

9

 
 

 

 
 

n/m

 
 

Increase in cash and cash equivalents

 
 

  572  

 
 

 

 
 

78

 
 

 

 
 

633

 
 
         
 

  Cash used in operating activities  

 
 

 
 

Higher cash used in operating activities in the first quarter of 2023 compared to the same period in 2022 was primarily due to lower net earnings from lower net realized selling prices in all segments and lower sales volumes in Retail, Potash and Phosphate.

 
 

  Cash used in investing activities  

 
 

 
 

Higher cash used in investing activities in the first quarter of 2023 compared to the same period in 2022 mainly due to higher spending to grow our Potash and Nitrogen operational capabilities through our plan to ramp up production and the proposed Geismar clean ammonia project, respectively, and higher spending on strategic Retail business acquisitions. We also continued to prioritize sustaining our assets to ensure we have safe and reliable operations.

 
 

  Cash provided by financing activities  

 
 



 
 

Higher cash provided by financing activities in the first quarter of 2023 compared to the same period in 2022 was due to the issuance of an aggregate principal amount of $1.5 billion of notes in the first quarter of 2023.
Proceeds from short-term debt increased from higher short-term borrowings in 2023 to temporarily finance our working capital requirements and support repurchases of common shares through our normal course issuer bid programs.

 
 

  Financial Condition Review  

 

The following balance sheet categories contain variances that are considered material:

 
                                                                                              
 

 

 
 

  As at  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

(millions of US dollars, except as otherwise noted)

 
 

  March 31, 2023  

 
 

 

 
 

December 31, 2022

 
 

 

 
 

$ Change

 
 

 

 
 

% Change

 
 

  Assets  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Cash and cash equivalents

 
 

  1,473  

 
 

 

 
 

901

 
 

 

 
 

572

 
 

 

 
 

63

 
 

Inventories

 
 

  9,852  

 
 

 

 
 

7,632

 
 

 

 
 

2,220

 
 

 

 
 

29

 
 

Prepaid expenses and other current assets

 
 

  937  

 
 

 

 
 

1,615

 
 

 

 
 

(678)

 
 

 

 
 

(42)

 
 

  Liabilities and Equity  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Short-term debt

 
 

  4,013  

 
 

 

 
 

2,142

 
 

 

 
 

1,871

 
 

 

 
 

87

 
 

Payables and accrued charges

 
 

  10,611  

 
 

 

 
 

11,291

 
 

 

 
 

(680)

 
 

 

 
 

(6)

 
 

Long-term debt

 
 

  9,510  

 
 

 

 
 

8,040

 
 

 

 
 

1,470

 
 

 

 
 

18

 
 

Share capital

 
 

  13,878  

 
 

 

 
 

14,172

 
 

 

 
 

(294)

 
 

 

 
 

(2)

 
 

Retained earnings

 
 

  11,660  

 
 

 

 
 

11,928

 
 

 

 
 

(268)

 
 

 

 
 

(2)

 
 
  • Explanations for changes in Cash and cash equivalents are in the "Sources and Uses of Cash" section above.
  •  
  •   Inventories increased due to seasonal Retail inventory build-up for the 2023 spring planting and application seasons in North America.
  •  
  •   Prepaid expenses and other current assets decreased due to Retail taking delivery of prepaid inventories in preparation for the spring planting and application seasons in North America.
  •  
  •   Short-term debt increased due to additional commercial paper issuances and borrowings under our credit facilities for our seasonal working capital requirements and for share repurchases under our normal course issuer bid programs.
  •  
  •   Payables and accrued charges decreased due to lower income tax payable from payments made for the 2022 tax balance and lower purchases driven by lower input costs. This was partially offset by seasonally high customer prepayments in North America.
  •  
  •   Long-term debt increased due to the issuance of an aggregate principal amount of $1.5 billion of notes in the first quarter of 2023.
  •  
  •   Share capital decreased primarily from shares repurchased under our normal course issuer bid programs.
  •  
  •   Retained earnings decreased as share repurchases and dividends declared in the quarter exceeded net earnings in the first quarter of 2023.
  •  

  Capital Structure and Management  

 

  Principal Debt Instruments  

 

As part of the normal course of business, we closely monitor our liquidity position. We use a combination of cash generated from operations and short-term and long-term debt to finance our operations. We were in compliance with our debt covenants and did not have any changes to our credit ratings in the three months ended March 31, 2023.

 
                                                                                                        
 

 

 
 

  As at March 31, 2023  

 
 

(millions of US dollars, except as

 
 

 

 
  

 

 
  

  Outstanding and Committed  

 
 

otherwise noted)

 
 

Rate of Interest (%)

 
 

 

 
 

Total Facility Limit

 
 

 

 
 

  Short-Term Debt  

 
 

 

 
 

  Long-Term Debt  

 
 

Credit facilities

 
 

 

 
  

 

 
  

 

 
  

 

 
 

Unsecured revolving term credit facility

 
 

n/a

 
  

4,500

 
  

  

 
  

  

 
 

Unsecured revolving term credit facility

 
 

5.9

 
  

2,000

 
  

  1,250  

 
  

  

 
 

Uncommitted revolving demand facility

 
 

n/a

 
  

1,000

 
  

  

 
  

  

 
 

Other credit facilities

 
 

 

 
  

1,240

 
  

 

 
  

 

 
 

South America

 
 

1.3 - 77.5

 
  

 

 
  

  484  

 
  

  157  

 
 

Australia

 
 

4.5

 
  

 

 
  

  147  

 
  

  

 
 

Other

 
 

0.8 - 4.0

 
  

 

 
  

  52  

 
  

  3  

 
 

Commercial paper

 
 

5.0 - 6.0

 
  

 

 
  

  1,905  

 
  

  

 
 

Other short-term and long-term debt

 
 

n/a

 
  

 

 
  

  175  

 
  

  7  

 
 

Total

 
 

 

 
  

 

 
  

  4,013  

 
  

  167  

 
 

The amount available under the commercial paper program is limited to the undrawn availability of backup funds under the $4,500 million unsecured revolving term credit facility and excess cash invested in highly liquid securities.

 

Our long-term debt consists primarily of notes and debentures. See the "Capital Structure and Management" section of our 2022 Annual Report for information on balances, rates and maturities for our notes and debentures. On March 27, 2023, we issued notes in the aggregate principal amount of $1.5 billion. See Note 8 to the interim financial statements.

 

  Outstanding Share Data  

 
      
 

 

 
 

  As at May 9, 2023  

 
 

Common shares

 
 

496,089,482

 
 

Options to purchase common shares

 
 

3,505,340

 
 

For more information on our capital structure and management, see Note 24 to our 2022 annual consolidated financial statements.

 

  Quarterly Results  

 
                                                                                                                          
 

(millions of US dollars, except as otherwise noted)

 
 

  Q1 2023  

 
 

Q4 2022

 
 

Q3 2022

 
 

Q2 2022

 
 

Q1 2022

 
 

Q4 2021

 
 

Q3 2021

 
 

Q2 2021

 
 

Sales

 
 

  6,107  

 
 

 

 
 

7,533

 
 

 

 
 

8,188

 
 

 

 
 

14,506

 
 

 

 
 

7,657

 
 

 

 
 

7,267

 
 

 

 
 

6,024

 
 

 

 
 

9,763

 
 

Net earnings

 
 

  576  

 
 

 

 
 

1,118

 
 

 

 
 

1,583

 
 

 

 
 

3,601

 
 

 

 
 

1,385

 
 

 

 
 

1,207

 
 

 

 
 

726

 
 

 

 
 

1,113

 
 

Net earnings attributable to equity holders of Nutrien

 
 

  571  

 
 

 

 
 

1,112

 
 

 

 
 

1,577

 
 

 

 
 

3,593

 
 

 

 
 

1,378

 
 

 

 
 

1,201

 
 

 

 
 

717

 
 

 

 
 

1,108

 
 

Net earnings per share attributable to

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

equity holders of Nutrien

 
               
 

Basic

 
 

  1.14  

 
 

 

 
 

2.15

 
 

 

 
 

2.95

 
 

 

 
 

6.53

 
 

 

 
 

2.49

 
 

 

 
 

2.11

 
 

 

 
 

1.26

 
 

 

 
 

1.94

 
 

Diluted

 
 

  1.14  

 
 

 

 
 

2.15

 
 

 

 
 

2.94

 
 

 

 
 

6.51

 
 

 

 
 

2.49

 
 

 

 
 

2.11

 
 

 

 
 

1.25

 
 

 

 
 

1.94

 
 

 

 
 

Seasonality in our business results from increased demand for products during the planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

 

Our earnings are significantly affected by fertilizer benchmark prices, which have been volatile over the last two years and are affected by demand-supply conditions, grower affordability and weather.

 

In the second and third quarters of 2022, earnings were impacted by $450 million and $330 million non-cash impairment reversals at Aurora and White Springs, respectively, of property, plant and equipment in the Phosphate segment related to higher forecasted global prices and a more favorable outlook for phosphate margins. In the fourth quarter of 2021, earnings were impacted by a $142 million loss resulting from the early extinguishment of long-term debt.

 

  Critical Accounting Estimates  

 

Our significant accounting policies are disclosed in our 2022 Annual Report. We have discussed the development, selection and application of our key accounting policies, and the critical accounting estimates and assumptions they involve, with the Audit Committee of the Board. Our critical accounting estimates are discussed on page 65 of our 2022 Annual Report. There were no material changes in the three months ended March 31, 2023 to our critical accounting estimates.

 

  Controls and Procedures  

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended, and National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings . Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with IFRS. Any system of internal control over financial reporting, no matter how well designed, has inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

 

There has been no change in our internal control over financial reporting during the three months ended March 31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

  Forward-Looking Statements  

 

Certain statements and other information included in this document, including within the "Market Outlook and Guidance" section, constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws (such statements are often accompanied by words such as "anticipate", "forecast", "expect", "believe", "may", "will", "should", "estimate", "intend" or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to: Nutrien's business strategies, plans, prospects and opportunities; Nutrien's revised 2023 full-year guidance, including expectations regarding our adjusted net earnings per share and adjusted EBITDA (consolidated and by segment); our projections for cash from operations; expectations regarding our growth and capital allocation intentions and strategies; our advancement of strategic growth initiatives; capital spending expectations for 2023; expectations regarding performance of our operating segments in 2023; our operating segment market outlooks and our expectations for market conditions and fundamentals in 2023 and beyond, and the anticipated supply and demand for our products and services, expected market and industry conditions with respect to crop nutrient application rates, planted acres, grower crop investment, crop mix, production volumes and expenses, shipments, consumption, prices and the impact of seasonality, including drought conditions, import and export volumes, economic sanctions, operating rates, natural gas curtailments and the war between Ukraine and Russia; Nutrien's ability to develop innovative and sustainable solutions; the negotiation of sales contracts; timing and impacts of plant turnarounds; acquisitions and divestitures and the anticipated benefits thereof; and expectations in connection with our ability to deliver long-term returns to shareholders. These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

 

All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty. The additional key assumptions that have been made include, among other things, assumptions with respect to our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and to realize the expected synergies on the anticipated timeline or at all; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, demand, supply, product availability, shipments, consumption, weather conditions, supplier agreements, availability and cost of labor and interest, exchange and effective tax rates; assumptions with respect to global economic conditions and the accuracy of our market outlook expectations for 2023 and in the future; our expectations for fertilizer prices to stabilize near mid-cycle values in 2023; assumptions with respect to our intention to complete share repurchases under our normal course issuer bid programs, including the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies; our expectations regarding any ongoing impacts, direct and indirect, of the COVID-19 pandemic on our business, customers, business partners, employees, supply chain, other stakeholders and the overall global economy; our expectations regarding the impacts, direct and indirect, of the war between Ukraine and Russia on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; our ability to maintain investment grade ratings and achieve our performance targets; our ability to successfully negotiate sales contracts; and our ability to successfully implement new initiatives and programs.

 

Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to complete announced and future acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including tariffs, trade restrictions and climate change initiatives), government ownership requirements, changes in environmental, tax and other laws or regulations and the interpretation thereof; political risks, including civil unrest, actions by armed groups or conflict and malicious acts including terrorism; the occurrence of a major environmental or safety incident; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; any ongoing impacts of the COVID-19 pandemic and its resulting effects on economic conditions and disruptions to global supply chains; the war between Ukraine and Russia and its potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments; the risk that rising interest rates and/or deteriorated business operating results may result in the impairment of assets or goodwill attributed to certain of our cash generating units; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC in the United States.

 

The purpose of our 2023 adjusted net earnings per share and adjusted EBITDA (consolidated and by segment) guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

 

The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.

 

  Terms and Definitions  

 

For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the "Terms & Definitions" section of our 2022 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, "n/m" indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.

 

  About Nutrien  

 

Nutrien is the world's largest provider of crop inputs and services, helping to safely and sustainably feed a growing world. We operate a world-class network of production, distribution and retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value for all stakeholders by advancing our key environmental, social and governance priorities.

 

More information about Nutrien can be found at www.nutrien.com .

 

Selected financial data for download can be found in our data tool at www.nutrien.com/investors/interactive-datatool  

 

Such data is not incorporated by reference herein.

 
 
 

 

 
 

  Nutrien will host a Conference Call on Thursday, May 11, 2023 at 10:00 a.m. Eastern Time.  

 

Telephone Conference dial-in numbers:

 
  • From Canada and the US 1-888-396-8049
  •  
  • International 1-416-764-8683
  •  
  • No access code required. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.
  •  

Live Audio Webcast: Visit https://www.nutrien.com/investors/events/2023-q1-earnings-conference-call  

 

  Appendix A - Selected Additional Financial Data  

 
                                                                                                                                          
 

  Selected Retail Measures  

 
 

  Three Months Ended March 31  

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

  Proprietary products gross margin (millions of US dollars)  

 
 

 

 
 

 

 
 

 

 
 

Crop nutrients

 
 

  54  

 
 

 

 
 

44

 
 

Crop protection products

 
 

  74  

 
 

 

 
 

111

 
 

Seed

 
 

  30  

 
 

 

 
 

26

 
 

Merchandise

 
 

  3  

 
 

 

 
 

3

 
 

All products

 
 

  161  

 
 

 

 
 

184

 
 

  Proprietary products margin as a percentage of product line margin (%)  

 
 

 

 
 

 

 
 

 

 
 

Crop nutrients

 
 

  38  

 
 

 

 
 

15

 
 

Crop protection products

 
 

  36  

 
 

 

 
 

39

 
 

Seed

 
 

  42  

 
 

 

 
 

38

 
 

Merchandise

 
 

  6  

 
 

 

 
 

7

 
 

All products

 
 

  26  

 
 

 

 
 

22

 
 

  Crop nutrients sales volumes (tonnes – thousands)  

 
 

 

 
 

 

 
 

 

 
 

North America

 
 

  1,195  

 
 

 

 
 

1,242

 
 

International

 
 

  845  

 
 

 

 
 

933

 
 

Total

 
 

  2,040  

 
 

 

 
 

2,175

 
 

  Crop nutrients selling price per tonne  

 
 

 

 
 

 

 
 

 

 
 

North America

 
 

  742  

 
 

 

 
 

867

 
 

International

 
 

  532  

 
 

 

 
 

547

 
 

Total

 
 

  655  

 
 

 

 
 

729

 
 

  Crop nutrients gross margin per tonne  

 
 

 

 
 

 

 
 

 

 
 

North America

 
 

  94  

 
 

 

 
 

185

 
 

International

 
 

  35  

 
 

 

 
 

67

 
 

Total

 
 

  69  

 
 

 

 
 

134

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  Financial performance measures  

 
 

  2023  

 
 

 

 
 

2022

 
 

Retail adjusted EBITDA margin (%) 1, 2

 
 

  10  

 
 

 

 
 

11

 
 

Retail adjusted EBITDA per US selling location (thousands of US dollars) 1, 2, 3

 
 

  1,709  

 
 

 

 
 

1,583

 
 

Retail adjusted average working capital to sales (%) 1, 4

 
 

  19  

 
 

 

 
 

14

 
 

Retail adjusted average working capital to sales excluding Nutrien Financial (%) 1, 4

 
 

  3  

 
 

 

 
 

 
 

Nutrien Financial adjusted net interest margin (%) 1, 4

 
 

  6.6  

 
 

 

 
 

6.9

 
 

Retail cash operating coverage ratio (%) 1, 4

 
 

  59  

 
 

 

 
 

57

 
 

1 Rolling four quarters ended March 31, 2023 and 2022.

 
 

2 These are supplementary financial measures. See the "Other Financial Measures" section.

 
 

3 Excluding acquisitions.

 
 

4 These are non-IFRS financial measures. See the "Non-IFRS Financial Measures" section.

 
 
                                                                     
 

  Nutrien Financial  

 
 

  As at March 31, 2023  

 
  

As at

 

December

 

31, 2022

 
 

(millions of US dollars)

 
 

  Current  

 
 

 

 
 

  

 

  Past Due  

 
 

 

 
 

  31–90 Days  

 

  Past Due  

 
 

 

 
 

  >90 Days  

 

  Past Due  

 
 

 

 
 

  Gross Receivables  

 
 

 

 
 

  Allowance 1  

 
 

 

 
 

  Net Receivables  

 
 

 

 
 

Net Receivables

 
 

North America

 
 

1,220

 
  

86

 
  

139

 
  

75

 
  

1,520

 
  

(28)

 
  

  1,492  

 
  

2,007

 
 

International

 
 

677

 
  

40

 
  

55

 
  

26

 
  

798

 
  

(7)

 
  

  791  

 
  

662

 
 

Nutrien Financial receivables

 
 

1,897

 
  

126

 
  

194

 
  

101

 
  

2,318

 
  

(35)

 
  

  2,283  

 
  

2,669

 
 

1 Bad debt expense on the above receivables for the three months ended March 31, 2023 was $1 million (2022 – $1 million) in the Retail segment.

 
 
                                              
 

  Selected Nitrogen Measures  

 
 

  Three Months Ended March 31  

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

  Sales volumes (tonnes – thousands)  

 
 

 

 
 

 

 
 

 

 
 

Fertilizer 1

 
 

  1,248  

 
 

 

 
 

1,153

 
 

Industrial and feed

 
 

  1,109  

 
 

 

 
 

1,172

 
 

  Net sales (millions of US dollars)  

 
 

 

 
 

 

 
 

 

 
 

Fertilizer 1

 
 

  681  

 
 

 

 
 

826

 
 

Industrial and feed

 
 

  498  

 
 

 

 
 

688

 
 

  Net selling price per tonne  

 
 

 

 
 

 

 
 

 

 
 

Fertilizer 1

 
 

  545  

 
 

 

 
 

716

 
 

Industrial and feed

 
 

  449  

 
 

 

 
 

587

 
 

1 Certain immaterial 2022 figures have been reclassified.

 
 

 

 
 

 

 
 

 

 
 
                                     
 

  Production Measures  

 
 

  Three Months Ended March 31  

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

Potash production (Product tonnes – thousands)

 
 

  3,088  

 
 

 

 
 

3,703

 
 

Potash shutdown weeks 1

 
 

  4  

 
 

 

 
 

 
 

Ammonia production – total 2

 
 

  1,431  

 
 

 

 
 

1,403

 
 

Ammonia production – adjusted 2, 3

 
 

  1,037  

 
 

 

 
 

958

 
 

Ammonia operating rate (%) 3

 
 

  95  

 
 

 

 
 

89

 
 

P 2 O 5 production (P 2 O 5 tonnes – thousands)

 
 

  341  

 
 

 

 
 

378

 
 

P 2 O 5 operating rate (%)

 
 

  81  

 
 

 

 
 

90

 
 

1 Represents weeks of full production shutdown, including inventory adjustments and unplanned events, excluding the impact of any periods of reduced operating rates, planned routine annual maintenance shutdowns and announced workforce reductions.

 
 

2 All figures are provided on a gross production basis in thousands of product tonnes.

 
 

3 Excludes Trinidad and Joffre.

 
 

  Appendix B - Non-IFRS Financial Measures  

 

We use both IFRS measures and certain non-IFRS financial measures to assess performance. Non-IFRS financial measures are financial measures disclosed by the Company that (a) depict historical or expected future financial performance, financial position or cash flow of the Company, (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company, (c) are not disclosed in the financial statements of the Company and (d) are not a ratio, fraction, percentage or similar representation. Non-IFRS ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-IFRS financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

 

These non-IFRS financial measures and non-IFRS ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-IFRS financial measures and non-IFRS ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-IFRS financial measures and non-IFRS ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

 

The following section outlines our non-IFRS financial measures and non-IFRS ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-IFRS financial measures and non-IFRS ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

 

  Adjusted EBITDA (Consolidated)  

 

  Most directly comparable IFRS financial measure: Net earnings (loss).

 

  Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and certain foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: integration and restructuring related costs, impairment or reversal of impairment of assets, COVID-19 related expenses, and gain or loss on disposal of certain businesses and investments.

 

  Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations, and as a component of employee remuneration calculations.

 
                                                    
 

 

 
 

  Three Months Ended March 31  

 
 

(millions of US dollars)

 
 

  2023  

 
 

 

 
 

2022

 
 

Net earnings

 
 

  576  

 
 

 

 
 

1,385

 
 

Finance costs

 
 

  170  

 
 

 

 
 

109

 
 

Income tax expense

 
 

  193  

 
 

 

 
 

505

 
 

Depreciation and amortization

 
 

  496  

 
 

 

 
 

461

 
 

EBITDA 1

 
 

  1,435  

 
 

 

 
 

2,460

 
 

Share-based compensation expense

 
 

  15  

 
 

 

 
 

135

 
 

Foreign exchange (gain) loss, net of related derivatives

 
 

  (34)  

 
 

 

 
 

25

 
 

Integration and restructuring related costs

 
 

  5  

 
 

 

 
 

9

 
 

COVID-19 related expenses 2

 
 

  

 
 

 

 
 

5

 
 

Gain on disposal of investment

 
 

  

 
 

 

 
 

(19)

 
 

Adjusted EBITDA

 
 

  1,421  

 
 

 

 
 

2,615

 
 

1 EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

 
 

2 COVID-19 related expenses primarily consist of increased cleaning and sanitization costs, the purchase of personal protective equipment, discretionary supplemental employee costs, and costs related to construction delays from access limitations and other government restrictions.

 
 

  Adjusted Net Earnings and Adjusted Net Earnings Per Share  

 

  Most directly comparable IFRS financial measure: Net earnings (loss) and net earnings (loss) per share.

 

  Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and certain foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, COVID-19 related expenses (including those recorded under finance costs), gain or loss on disposal of certain businesses and investments, and gain/loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting. We generally apply the annual forecasted effective tax rate to our adjustments during the year and, at year-end, we apply the actual effective tax rate. If the effective tax rate is significantly different from our forecasted effective tax rate due to adjustments or discrete tax impacts, we apply a tax rate that excludes those items. For material adjustments, we apply a tax rate specific to the adjustment.

 

  Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

 
                                                                                                                                  
 

 

 
 

  Three Months Ended  

 

  March 31, 2023  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  Per  

 
 

 

 
 

  Increases  

 
 

 

 
 

 

 
 

 

 
 

  Diluted  

 
 

(millions of US dollars, except as otherwise noted)

 
 

  (Decreases)  

 
 

 

 
 

  Post-Tax  

 
 

 

 
 

  Share  

 
 

Net earnings attributable to equity holders of Nutrien

 
 

 

 
 

 

 
 

571

 
 

 

 
 

1.14

 
 

Adjustments:

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Share-based compensation expense

 
 

15

 
 

 

 
 

11

 
 

 

 
 

0.01

 
 

Foreign exchange gain, net of related derivatives

 
 

(34)

 
 

 

 
 

(25)

 
 

 

 
 

(0.05)

 
 

Integration and restructuring related costs

 
 

5

 
 

 

 
 

4

 
 

 

 
 

0.01

 
 

Adjusted net earnings

 
 

 

 
 

 

 
 

  561  

 
 

 

 
 

  1.11  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Three Months Ended

 

March 31, 2022

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Per

 
 

 

 
 

Increases

 
 

 

 
 

 

 
 

 

 
 

Diluted

 
 

(millions of US dollars, except as otherwise noted)

 
 

(Decreases)

 
 

 

 
 

Post-Tax

 
 

 

 
 

Share

 
 

Net earnings attributable to equity holders of Nutrien

 
 

 

 
 

 

 
 

1,378

 
 

 

 
 

2.49

 
 

Adjustments:

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Share-based compensation expense

 
 

135

 
 

 

 
 

101

 
 

 

 
 

0.18

 
 

Foreign exchange loss, net of related derivatives

 
 

25

 
 

 

 
 

19

 
 

 

 
 

0.04

 
 

Integration and restructuring related costs

 
 

9

 
 

 

 
 

7

 
 

 

 
 

0.01

 
 

COVID-19 related expenses

 
 

5

 
 

 

 
 

4

 
 

 

 
 

0.01

 
 

Gain on disposal of investment

 
 

(19)

 
 

 

 
 

(14)

 
 

 

 
 

(0.03)

 
 

Adjusted net earnings

 
 

 

 
 

 

 
 

1,495

 
 

 

 
 

2.70

 
 

  Adjusted EBITDA (Consolidated) and Adjusted Net Earnings Per Share Guidance  

 

Adjusted EBITDA and adjusted net earnings per share guidance are forward-looking non-IFRS financial measures. We do not provide a reconciliation of such forward-looking measures to the most directly comparable financial measures calculated and presented in accordance with IFRS because a meaningful or accurate calculation of reconciling items and the information is not available without unreasonable effort due to unknown variables, including the timing and amount of certain reconciling items, and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. The probable significance of such unavailable information, which could be material to future results, cannot be addressed. Guidance for adjusted EBITDA and adjusted net earnings per share excludes certain items such as, but not limited to, the impacts of share-based compensation, certain foreign exchange gain/loss (net of related derivatives), integration and restructuring related costs, impairment or reversal of impairment of assets, COVID-19 related expenses (including those recorded under finance costs), gain or loss on disposal of certain businesses and investments, and gain/loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting.

 

  Gross Margin Excluding Depreciation and Amortization Per Tonne - Manufactured  

 

  Most directly comparable IFRS financial measure: Gross margin.

 

  Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the "Segment Results" section.

 

  Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

 

  Potash Controllable Cash Cost of Product Manufactured ("COPM") Per Tonne  

 

  Most directly comparable IFRS financial measure: Cost of goods sold ("COGS") for the Potash segment.

 

  Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

 

  Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

 
                                               
 

 

 
 

  Three Months Ended March 31  

 
 

(millions of US dollars, except as otherwise noted)

 
 

  2023  

 
 

 

 
 

2022

 
 

Total COGS – Potash

 
 

  305  

 
 

 

 
 

305

 
 

Change in inventory

 
 

  40  

 
 

 

 
 

77

 
 

Other adjustments 1

 
 

  (8)  

 
 

 

 
 

(15)

 
 

COPM

 
 

  337  

 
 

 

 
 

367

 
 

Depreciation and amortization in COPM

 
 

  (100)  

 
 

 

 
 

(119)

 
 

Royalties in COPM

 
 

  (31)  

 
 

 

 
 

(45)

 
 

Natural gas costs and carbon taxes in COPM

 
 

  (16)  

 
 

 

 
 

(17)

 
 

Controllable cash COPM

 
 

  190  

 
 

 

 
 

186

 
 

Production tonnes (tonnes – thousands)

 
 

  3,088  

 
 

 

 
 

3,703

 
 

Potash controllable cash COPM per tonne

 
 

  62  

 
 

 

 
 

50

 
 

1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

 
 

  Ammonia Controllable Cash COPM Per Tonne  

 

  Most directly comparable IFRS financial measure: Total manufactured COGS for the Nitrogen segment.

 

  Definition: Total Nitrogen COGS excluding depreciation and amortization expense included in COGS, cash COGS for products other than ammonia, other adjustments, and natural gas and steam costs, divided by net ammonia production tonnes.

 

  Why we use the measure and why it is useful to investors: To assess operational performance. Ammonia controllable cash COPM excludes the effects of production from other periods, the costs of natural gas and steam, and long-term investment decisions, supporting a focus on the performance of our day-to-day operations.

 
                                                                
 

 

 
 

  Three Months Ended March 31  

 
 

(millions of US dollars, except as otherwise noted)

 
 

  2023  

 
 

 

 
 

2022

 
 

Total Manufactured COGS – Nitrogen 1

 
 

  648  

 
 

 

 
 

672

 
 

Total Other COGS – Nitrogen 1

 
 

  123  

 
 

 

 
 

209

 
 

Total COGS – Nitrogen

 
 

  771  

 
 

 

 
 

881

 
 

Depreciation and amortization in COGS

 
 

  (108)  

 
 

 

 
 

(102)

 
 

Cash COGS for products other than ammonia

 
 

  (471)  

 
 

 

 
 

(524)

 
 

Ammonia

 
 

 

 
 

 

 
 

 

 
 

Total cash COGS before other adjustments

 
 

  192  

 
 

 

 
 

255

 
 

Other adjustments 2

 
 

  (68)  

 
 

 

 
 

(36)

 
 

Total cash COPM

 
 

  124  

 
 

 

 
 

219

 
 

Natural gas and steam costs in COPM

 
 

  (85)  

 
 

 

 
 

(181)

 
 

Controllable cash COPM

 
 

  39  

 
 

 

 
 

38

 
 

Production tonnes (net tonnes 3 – thousands)

 
 

  628  

 
 

 

 
 

674

 
 

Ammonia controllable cash COPM per tonne

 
 

  63  

 
 

 

 
 

56

 
 

1 Certain immaterial 2022 figures have been reclassified.

 
 

 

 
 

 

 
 

 

 
 

2 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

 
 

3 Ammonia tonnes available for sale, as not upgraded to other nitrogen products.

 
 

  Retail Adjusted Average Working Capital to Sales and Retail Adjusted Average Working   Capital to Sales Excluding Nutrien Financial  

 

  Definition: Retail adjusted average working capital divided by Retail adjusted sales for the last four rolling quarters. We exclude in our calculations the sales and working capital of certain acquisitions during the first year following the acquisition. We also look at this metric excluding Nutrien Financial revenue and working capital.

 

  Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively. The metric excluding Nutrien Financial shows the impact that the working capital of Nutrien Financial has on the ratio.

 
                                                                                                                                                                                                                                                                                                                                                        
 

 

 
 

  Rolling four quarters ended March 31, 2023  

 
 

(millions of US dollars, except as otherwise noted)

 
 

  Q2 2022  

 
 

 

 
 

  Q3 2022  

 
 

 

 
 

  Q4 2022  

 
 

 

 
 

  Q1 2023  

 
 

 

 
 

  Average/Total  

 
 

Current assets

 
 

12,487

 
 

 

 
 

11,262

 
 

 

 
 

11,668

 
 

 

 
 

13,000

 
 

 

 
 

 

 
 

Current liabilities

 
 

(9,177)

 
 

 

 
 

(5,889)

 
 

 

 
 

(8,708)

 
 

 

 
 

(8,980)

 
 

 

 
 

 

 
 

Working capital

 
 

3,310

 
 

 

 
 

5,373

 
 

 

 
 

2,960

 
 

 

 
 

4,020

 
 

 

 
 

  3,916  

 
 

Working capital from certain recent acquisitions

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 

 
 

Adjusted working capital

 
 

3,310

 
 

 

 
 

5,373

 
 

 

 
 

2,960

 
 

 

 
 

4,020

 
 

 

 
 

  3,916  

 
 

Nutrien Financial working capital

 
 

(4,404)

 
 

 

 
 

(3,898)

 
 

 

 
 

(2,669)

 
 

 

 
 

(2,283)

 
 

 

 
 

 

 
 

Adjusted working capital excluding Nutrien Financial

 
 

(1,094)

 
 

 

 
 

1,475

 
 

 

 
 

291

 
 

 

 
 

1,737

 
 

 

 
 

  602  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Sales

 
 

9,422

 
 

 

 
 

3,980

 
 

 

 
 

4,087

 
 

 

 
 

3,422

 
 

 

 
 

 

 
 

Sales from certain recent acquisitions

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 

 
 

Adjusted sales

 
 

9,422

 
 

 

 
 

3,980

 
 

 

 
 

4,087

 
 

 

 
 

3,422

 
 

 

 
 

  20,911  

 
 

Nutrien Financial revenue

 
 

(91)

 
 

 

 
 

(65)

 
 

 

 
 

(62)

 
 

 

 
 

(57)

 
 

 

 
 

 

 
 

Adjusted sales excluding Nutrien Financial

 
 

9,331

 
 

 

 
 

3,915

 
 

 

 
 

4,025

 
 

 

 
 

3,365

 
 

 

 
 

  20,636  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  Adjusted average working capital to sales (%)  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  19  

 
 

  Adjusted average working capital to sales excluding Nutrien Financial (%)  

 
 

 

 
 

 

 
 

 

 
 

  3  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Rolling four quarters ended March 31, 2022

 
 

(millions of US dollars, except as otherwise noted)

 
 

Q2 2021

 
 

 

 
 

Q3 2021

 
 

 

 
 

Q4 2021

 
 

 

 
 

Q1 2022

 
 

 

 
 

Average/Total

 
 

Current assets

 
 

9,300

 
 

 

 
 

8,945

 
 

 

 
 

9,924

 
 

 

 
 

12,392

 
 

 

 
 

 

 
 

Current liabilities

 
 

(7,952)

 
 

 

 
 

(5,062)

 
 

 

 
 

(7,828)

 
 

 

 
 

(9,223)

 
 

 

 
 

 

 
 

Working capital

 
 

1,348

 
 

 

 
 

3,883

 
 

 

 
 

2,096

 
 

 

 
 

3,169

 
 

 

 
 

2,624

 
 

Working capital from certain recent acquisitions

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 

 
 

Adjusted working capital

 
 

1,348

 
 

 

 
 

3,883

 
 

 

 
 

2,096

 
 

 

 
 

3,169

 
 

 

 
 

2,624

 
 

Nutrien Financial working capital

 
 

(3,072)

 
 

 

 
 

(2,820)

 
 

 

 
 

(2,150)

 
 

 

 
 

(2,274)

 
 

 

 
 

 

 
 

Adjusted working capital excluding Nutrien Financial

 
 

(1,724)

 
 

 

 
 

1,063

 
 

 

 
 

(54)

 
 

 

 
 

895

 
 

 

 
 

45

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Sales

 
 

7,537

 
 

 

 
 

3,347

 
 

 

 
 

3,878

 
 

 

 
 

3,861

 
 

 

 
 

 

 
 

Sales from certain recent acquisitions

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 

 
 

Adjusted sales

 
 

7,537

 
 

 

 
 

3,347

 
 

 

 
 

3,878

 
 

 

 
 

3,861

 
 

 

 
 

18,623

 
 

Nutrien Financial revenue

 
 

(59)

 
 

 

 
 

(54)

 
 

 

 
 

(51)

 
 

 

 
 

(49)

 
 

 

 
 

 

 
 

Adjusted sales excluding Nutrien Financial

 
 

7,478

 
 

 

 
 

3,293

 
 

 

 
 

3,827

 
 

 

 
 

3,812

 
 

 

 
 

18,410

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Adjusted average working capital to sales (%)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

14

 
 

Adjusted average working capital to sales excluding Nutrien Financial (%)

 
 

 

 
 

 

 
 

 

 
 

 
 

  Nutrien Financial Adjusted Net Interest Margin  

 

  Definition: Nutrien Financial revenue less deemed interest expense divided by average Nutrien Financial net receivables outstanding for the last four rolling quarters.

 

  Why we use the measure and why it is useful to investors: Used by credit rating agencies and other users to evaluate the financial performance of Nutrien Financial.

 
                                                                                                                                                           
 

 

 
 

  Rolling four quarters ended March 31, 2023  

 
 

(millions of US dollars, except as otherwise noted)

 
 

  Q2 2022  

 
 

 

 
 

  Q3 2022  

 
 

 

 
 

  Q4 2022  

 
 

 

 
 

  Q1 2023  

 
 

 

 
 

  Total/Average  

 
 

Nutrien Financial revenue

 
 

91

 
 

 

 
 

65

 
 

 

 
 

62

 
 

 

 
 

57

 
 

 

 
 

 

 
 

Deemed interest expense 1

 
 

(12)

 
 

 

 
 

(12)

 
 

 

 
 

(11)

 
 

 

 
 

(20)

 
 

 

 
 

 

 
 

Net interest

 
 

79

 
 

 

 
 

53

 
 

 

 
 

51

 
 

 

 
 

37

 
 

 

 
 

  220  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Average Nutrien Financial net receivables

 
 

4,404

 
 

 

 
 

3,898

 
 

 

 
 

2,669

 
 

 

 
 

2,283

 
 

 

 
 

  3,314  

 
 

Nutrien Financial adjusted net interest margin (%)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  6.6  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Rolling four quarters ended March 31, 2022

 
 

(millions of US dollars, except as otherwise noted)

 
 

Q2 2021

 
 

 

 
 

Q3 2021

 
 

 

 
 

Q4 2021

 
 

 

 
 

Q1 2022

 
 

 

 
 

Total/Average

 
 

Nutrien Financial revenue

 
 

59

 
 

 

 
 

54

 
 

 

 
 

51

 
 

 

 
 

49

 
 

 

 
 

 

 
 

Deemed interest expense 1

 
 

(8)

 
 

 

 
 

(10)

 
 

 

 
 

(12)

 
 

 

 
 

(6)

 
 

 

 
 

 

 
 

Net interest

 
 

51

 
 

 

 
 

44

 
 

 

 
 

39

 
 

 

 
 

43

 
 

 

 
 

177

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Average Nutrien Financial net receivables

 
 

3,072

 
 

 

 
 

2,820

 
 

 

 
 

2,150

 
 

 

 
 

2,274

 
 

 

 
 

2,579

 
 

Nutrien Financial adjusted net interest margin (%)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

6.9

 
 

1 Average borrowing rate applied to the notional debt required to fund the portfolio of receivables from customers monitored and serviced by Nutrien Financial.

 
 

  Retail Cash Operating Coverage Ratio  

 

  Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

 

  Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate free cash flow.

 
                                                                                                                                                                                                                                                              
 

 

 
 

  Rolling four quarters ended March 31, 2023  

 
 

(millions of US dollars, except as otherwise noted)

 
 

  Q2 2022  

 
 

 

 
 

  Q3 2022  

 
 

 

 
 

  Q4 2022  

 
 

 

 
 

  Q1 2023  

 
 

 

 
 

  Total  

 
 

Selling expenses

 
 

1,013

 
 

 

 
 

821

 
 

 

 
 

836

 
 

 

 
 

765

 
 

 

 
 

  3,435  

 
 

General and administrative expenses

 
 

54

 
 

 

 
 

50

 
 

 

 
 

51

 
 

 

 
 

50

 
 

 

 
 

  205  

 
 

Other expenses

 
 

21

 
 

 

 
 

19

 
 

 

 
 

1

 
 

 

 
 

15

 
 

 

 
 

  56  

 
 

Operating expenses

 
 

1,088

 
 

 

 
 

890

 
 

 

 
 

888

 
 

 

 
 

830

 
 

 

 
 

  3,696  

 
 

Depreciation and amortization in operating expenses

 
 

(171)

 
 

 

 
 

(204)

 
 

 

 
 

(198)

 
 

 

 
 

(179)

 
 

 

 
 

  (752)  

 
 

Operating expenses excluding depreciation and amortization

 
 

917

 
 

 

 
 

686

 
 

 

 
 

690

 
 

 

 
 

651

 
 

 

 
 

  2,944  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Gross margin

 
 

2,340

 
 

 

 
 

917

 
 

 

 
 

1,077

 
 

 

 
 

615

 
 

 

 
 

  4,949  

 
 

Depreciation and amortization in cost of goods sold

 
 

4

 
 

 

 
 

2

 
 

 

 
 

4

 
 

 

 
 

2

 
 

 

 
 

  12  

 
 

Gross margin excluding depreciation and amortization

 
 

2,344

 
 

 

 
 

919

 
 

 

 
 

1,081

 
 

 

 
 

617

 
 

 

 
 

  4,961  

 
 

Cash operating coverage ratio (%)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  59  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Rolling four quarters ended March 31, 2022

 
 

(millions of US dollars, except as otherwise noted)

 
 

Q2 2021

 
 

 

 
 

Q3 2021

 
 

 

 
 

Q4 2021

 
 

 

 
 

Q1 2022

 
 

 

 
 

Total

 
 

Selling expenses

 
 

863

 
 

 

 
 

746

 
 

 

 
 

848

 
 

 

 
 

722

 
 

 

 
 

3,179

 
 

General and administrative expenses

 
 

41

 
 

 

 
 

45

 
 

 

 
 

43

 
 

 

 
 

45

 
 

 

 
 

174

 
 

Other expenses (income)

 
 

34

 
 

 

 
 

17

 
 

 

 
 

20

 
 

 

 
 

(12)

 
 

 

 
 

59

 
 

Operating expenses

 
 

938

 
 

 

 
 

808

 
 

 

 
 

911

 
 

 

 
 

755

 
 

 

 
 

3,412

 
 

Depreciation and amortization in operating expenses

 
 

(166)

 
 

 

 
 

(180)

 
 

 

 
 

(173)

 
 

 

 
 

(167)

 
 

 

 
 

(686)

 
 

Operating expenses excluding depreciation and amortization

 
 

772

 
 

 

 
 

628

 
 

 

 
 

738

 
 

 

 
 

588

 
 

 

 
 

2,726

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Gross margin

 
 

1,858

 
 

 

 
 

917

 
 

 

 
 

1,173

 
 

 

 
 

845

 
 

 

 
 

4,793

 
 

Depreciation and amortization in cost of goods sold

 
 

3

 
 

 

 
 

2

 
 

 

 
 

5

 
 

 

 
 

2

 
 

 

 
 

12

 
 

Gross margin excluding depreciation and amortization

 
 

1,861

 
 

 

 
 

919

 
 

 

 
 

1,178

 
 

 

 
 

847

 
 

 

 
 

4,805

 
 

Cash operating coverage ratio (%)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

57

 
 

  Appendix C – Other Financial Measures  

 

  Supplementary Financial Measures  

 

Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-IFRS financial measures, and (d) are not non-IFRS ratios.

 

The following section provides an explanation of the composition of those supplementary financial measures if not previously provided.

 

  Retail adjusted EBITDA margin: Retail adjusted EBITDA divided by Retail sales for the last four rolling quarters.

 

  Retail adjusted EBITDA per US selling location: Calculated as total Retail US adjusted EBITDA for the last four rolling quarters, representing the organic EBITDA component, which excludes acquisitions in those quarters, divided by the number of US locations that have generated sales in the last four rolling quarters, adjusted for acquired locations in those quarters.

 

  Cash used for dividends and share repurchases (shareholder returns): Calculated as dividends paid to Nutrien's shareholders plus repurchase of common shares as reflected in the condensed consolidated statements of cash flows. This measure is useful as it represents return of capital to shareholders.

 

  Condensed Consolidated Financial Statements  

 

  Unaudited in millions of US dollars except as otherwise noted  

 

  Condensed Consolidated Statements of Earnings  

 
                                                                                                                                                              
 

 

 
 

 

 
  

  Three Months Ended  

 
 

 

 
 

 

 
  

  March 31  

 
 

 

 
 

Note

 
  

  2023  

 
 

 

 
 

2022

 
 

  SALES  

 
 

2

 
  

  6,107  

 
 

 

 
 

7,657

 
 

Freight, transportation and distribution

 
 

 

 
  

  199  

 
 

 

 
 

203

 
 

Cost of goods sold

 
 

 

 
  

  3,995  

 
 

 

 
 

4,197

 
 

  GROSS MARGIN  

 
 

 

 
  

  1,913  

 
 

 

 
 

3,257

 
 

Selling expenses

 
 

 

 
  

  770  

 
 

 

 
 

727

 
 

General and administrative expenses

 
 

 

 
  

  145  

 
 

 

 
 

126

 
 

Provincial mining taxes

 
 

 

 
  

  119  

 
 

 

 
 

249

 
 

Share-based compensation expense

 
 

 

 
  

  15  

 
 

 

 
 

135

 
 

Other (income) expenses

 
 

4

 
  

  (75)  

 
 

 

 
 

21

 
 

  EARNINGS BEFORE FINANCE COSTS AND INCOME TAXES  

 
  

  939  

 
 

 

 
 

1,999

 
 

Finance costs

 
 

 

 
  

  170  

 
 

 

 
 

109

 
 

  EARNINGS BEFORE INCOME TAXES  

 
 

 

 
  

  769  

 
 

 

 
 

1,890

 
 

Income tax expense

 
 

5

 
  

  193  

 
 

 

 
 

505

 
 

  NET EARNINGS  

 
 

 

 
  

  576  

 
 

 

 
 

1,385

 
 

Attributable to

 
 

 

 
  

 

 
 

 

 
 

 

 
 

Equity holders of Nutrien

 
 

 

 
  

  571  

 
 

 

 
 

1,378

 
 

Non-controlling interest

 
 

 

 
  

  5  

 
 

 

 
 

7

 
 

  NET EARNINGS  

 
 

 

 
  

  576  

 
 

 

 
 

1,385

 
 

 

 
 

 

 
  

 

 
 

 

 
 

 

 
 

  NET EARNINGS PER SHARE ATTRIBUTABLE TO EQUITY HOLDERS OF NUTRIEN ("EPS")  

 
 

Basic

 
 

 

 
  

  1.14  

 
 

 

 
 

2.49

 
 

Diluted

 
 

 

 
  

  1.14  

 
 

 

 
 

2.49

 
 

Weighted average shares outstanding for basic EPS

 
 

 

 
  

  501,175,000  

 
 

 

 
 

552,636,000

 
 

Weighted average shares outstanding for diluted EPS

 
 

 

 
  

  502,220,000  

 
 

 

 
 

554,647,000

 
 

 

 
 

 

 
  

 

 
 

 

 
 

 

 
 

  Condensed Consolidated Statements of Comprehensive Income  

 
                                                                     
 

 

 
 

  Three Months Ended  

 
 

 

 
 

  March 31  

 
 

(Net of related income taxes)

 
 

  2023  

 
 

 

 
 

2022

 
 

  NET EARNINGS  

 
 

  576  

 
 

 

 
 

1,385

 
 

Other comprehensive income

 
 

 

 
 

 

 
 

 

 
 

Items that will not be reclassified to net earnings:

 
 

 

 
 

 

 
 

 

 
 

Net actuarial (loss) gain on defined benefit plans

 
 

  (3)  

 
 

 

 
 

1

 
 

Net fair value gain on investments

 
 

  5  

 
 

 

 
 

31

 
 

Items that have been or may be subsequently reclassified to net earnings:

 
 

 

 
 

 

 
 

 

 
 

Gain on currency translation of foreign operations

 
 

  1  

 
 

 

 
 

128

 
 

Other

 
 

  (1)  

 
 

 

 
 

16

 
 

  OTHER COMPREHENSIVE INCOME  

 
 

  2  

 
 

 

 
 

176

 
 

  COMPREHENSIVE INCOME  

 
 

  578  

 
 

 

 
 

1,561

 
 

Attributable to

 
 

 

 
 

 

 
 

 

 
 

Equity holders of Nutrien

 
 

  573  

 
 

 

 
 

1,554

 
 

Non-controlling interest

 
 

  5  

 
 

 

 
 

7

 
 

  COMPREHENSIVE INCOME  

 
 

  578  

 
 

 

 
 

1,561

 
 

 

 
 

 

 
 

 

 
 

 

 
 

(See Notes to the Condensed Consolidated Financial Statements)

 
 

  Condensed Consolidated Statements of Cash Flows  

 
                                                                                                                                                                                                                                                                                                                 
 

 

 
 

 

 
  

  Three Months Ended  

 
 

 

 
 

 

 
  

  March 31  

 
 

 

 
 

Note

 
  

  2023  

 
 

 

 
 

2022

 
 

 

 
 

 

 
  

 

 
 

 

 
 

Note 1

 
 

  OPERATING ACTIVITIES  

 
 

 

 
  

 

 
 

 

 
 

 

 
 

Net earnings

 
 

 

 
  

  576  

 
 

 

 
 

1,385

 
 

Adjustments for:

 
 

 

 
  

 

 
 

 

 
 

 

 
 

Depreciation and amortization

 
 

 

 
  

  496  

 
 

 

 
 

461

 
 

Share-based compensation expense

 
 

 

 
  

  15  

 
 

 

 
 

135

 
 

Gain on disposal of investment

 
 

 

 
  

  

 
 

 

 
 

(19)

 
 

Provision for deferred income tax

 
 

 

 
  

  21  

 
 

 

 
 

45

 
 

Long-term income tax receivables

 
 

 

 
  

  (72)  

 
 

 

 
 

10

 
 

Net distributed (undistributed) earnings of equity-accounted investees

 
 

 

 
  

  163  

 
 

 

 
 

(39)

 
 

Gain on amendments to other post-retirement pension plans

 
 

 

 
  

  (80)  

 
 

 

 
 

 
 

Other long-term assets, liabilities and miscellaneous

 
 

 

 
  

  7  

 
 

 

 
 

30

 
 

Cash from operations before working capital changes

 
 

 

 
  

  1,126  

 
 

 

 
 

2,008

 
 

Changes in non-cash operating working capital:

 
 

 

 
  

 

 
 

 

 
 

 

 
 

Receivables

 
 

 

 
  

  535  

 
 

 

 
 

(909)

 
 

Inventories

 
 

 

 
  

  (2,168)  

 
 

 

 
 

(2,609)

 
 

Prepaid expenses and other current assets

 
 

 

 
  

  675  

 
 

 

 
 

722

 
 

Payables and accrued charges

 
 

 

 
  

  (1,026)  

 
 

 

 
 

726

 
 

  CASH USED IN OPERATING ACTIVITIES  

 
 

 

 
  

  (858)  

 
 

 

 
 

(62)

 
 

  INVESTING ACTIVITIES  

 
 

 

 
  

 

 
 

 

 
 

 

 
 

Capital expenditures 1

 
 

 

 
  

  (450)  

 
 

 

 
 

(351)

 
 

Business acquisitions, net of cash acquired

 
 

 

 
  

  (111)  

 
 

 

 
 

(41)

 
 

Other

 
 

 

 
  

  (33)  

 
 

 

 
 

34

 
 

Net changes in non-cash working capital

 
 

 

 
  

  (100)  

 
 

 

 
 

(99)

 
 

  CASH USED IN INVESTING ACTIVITIES  

 
 

 

 
  

  (694)  

 
 

 

 
 

(457)

 
 

  FINANCING ACTIVITIES  

 
 

 

 
  

 

 
 

 

 
 

 

 
 

Transaction costs related to debt

 
 

 

 
  

  (20)  

 
 

 

 
 

 
 

Proceeds from short-term debt, net

 
 

7

 
  

  1,873  

 
 

 

 
 

1,454

 
 

Proceeds from long-term debt

 
 

8

 
  

  1,500  

 
 

 

 
 

 
 

Repayment of long-term debt

 
 

 

 
  

  (17)  

 
 

 

 
 

(2)

 
 

Repayment of principal portion of lease liabilities

 
 

 

 
  

  (87)  

 
 

 

 
 

(79)

 
 

Dividends paid to Nutrien's shareholders

 
 

9

 
  

  (246)  

 
 

 

 
 

(257)

 
 

Repurchase of common shares

 
 

9

 
  

  (897)  

 
 

 

 
 

(642)

 
 

Issuance of common shares

 
 

 

 
  

  28  

 
 

 

 
 

126

 
 

Other

 
 

 

 
  

  (5)  

 
 

 

 
 

(12)

 
 

  CASH PROVIDED BY FINANCING ACTIVITIES  

 
 

 

 
  

  2,129  

 
 

 

 
 

588

 
 

  EFFECT OF EXCHANGE RATE CHANGES ON CASH AND   CASH EQUIVALENTS  

 
 

 

 
  

  (5)  

 
 

 

 
 

9

 
 

  INCREASE IN CASH AND CASH EQUIVALENTS  

 
 

 

 
  

  572  

 
 

 

 
 

78

 
 

  CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD  

 
 

 

 
  

  901  

 
 

 

 
 

499

 
 

  CASH AND CASH EQUIVALENTS – END OF PERIOD  

 
 

 

 
  

  1,473  

 
 

 

 
 

577

 
 

Cash and cash equivalents is composed of:

 
 

 

 
  

 

 
 

 

 
 

 

 
 

Cash

 
 

 

 
  

  361  

 
 

 

 
 

546

 
 

Short-term investments

 
 

 

 
  

  1,112  

 
 

 

 
 

31

 
 

 

 
 

 

 
  

  1,473  

 
 

 

 
 

577

 
 

  SUPPLEMENTAL CASH FLOWS INFORMATION  

 
 

 

 
  

 

 
 

 

 
 

 

 
 

Interest paid

 
 

 

 
  

  98  

 
 

 

 
 

50

 
 

Income taxes paid

 
 

 

 
  

  1,319  

 
 

 

 
 

789

 
 

Total cash outflow for leases

 
 

 

 
  

  119  

 
 

 

 
 

107

 
 

1 Includes additions to property, plant and equipment, and intangible assets for the three months ended March 31, 2023 of $411 and $39 (2022 – $306 and $45), respectively.

 
 

 

 
 

(See Notes to the Condensed Consolidated Financial Statements)

 
 

  Condensed Consolidated Statements of Changes in Shareholders' Equity  

 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Accumulated Other Comprehensive

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

(Loss) Income ("AOCI")

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Loss on

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Currency

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Equity

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Number of

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Translation

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Holders

 
 

 

 
 

Non-

 
 

 

 
 

 

 
 

 

 
 

Common

 
 

 

 
 

Share

 
 

 

 
 

Contributed

 
 

 

 
 

of Foreign

 
 

 

 
 

 

 
 

 

 
 

Total

 
 

 

 
 

Retained

 
 

 

 
 

of

 
 

 

 
 

Controlling

 
 

 

 
 

Total

 
 

 

 
 

Shares

 
 

 

 
 

Capital

 
 

 

 
 

Surplus

 
 

 

 
 

Operations

 
 

 

 
 

Other

 
 

 

 
 

AOCI

 
 

 

 
 

Earnings

 
 

 

 
 

Nutrien

 
 

 

 
 

Interest

 
 

 

 
 

Equity

 
 

  BALANCE – DECEMBER 31, 2021  

 
 

557,492,516

 
 

 

 
 

15,457

 
 

 

 
 

149

 
 

 

 
 

(176)

 
 

 

 
 

30

 
 

 

 
 

(146)

 
 

 

 
 

8,192

 
 

 

 
 

23,652

 
 

 

 
 

47

 
 

 

 
 

23,699

 
 

Net earnings

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

1,378

 
 

 

 
 

1,378

 
 

 

 
 

7

 
 

 

 
 

1,385

 
 

Other comprehensive income

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

128

 
 

 

 
 

48

 
 

 

 
 

176

 
 

 

 
 

 
 

 

 
 

176

 
 

 

 
 

 
 

 

 
 

176

 
 

Shares repurchased (Note 9)

 
 

(7,648,235)

 
 

 

 
 

(212)

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

(375)

 
 

 

 
 

(587)

 
 

 

 
 

 
 

 

 
 

(587)

 
 

Dividends declared

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

(265)

 
 

 

 
 

(265)

 
 

 

 
 

 
 

 

 
 

(265)

 
 

Non-controlling interest transactions

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

(11)

 
 

 

 
 

(11)

 
 

Effect of share-based compensation including issuance of

 
                   
 

common shares

 
 

2,275,861

 
 

 

 
 

153

 
 

 

 
 

(16)

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

137

 
 

 

 
 

 
 

 

 
 

137

 
 

Transfer of net gain on cash flow hedges

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

(3)

 
 

 

 
 

(3)

 
 

 

 
 

 
 

 

 
 

(3)

 
 

 

 
 

 
 

 

 
 

(3)

 
 

Transfer of net actuarial gain on defined benefit plans

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

(1)

 
 

 

 
 

(1)

 
 

 

 
 

1

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

  BALANCE – MARCH 31, 2022  

 
 

552,120,142

 
 

 

 
 

15,398

 
 

 

 
 

133

 
 

 

 
 

(48)

 
 

 

 
 

74

 
 

 

 
 

26

 
 

 

 
 

8,931

 
 

 

 
 

24,488

 
 

 

 
 

43

 
 

 

 
 

24,531

 
 

  BALANCE – DECEMBER 31, 2022  

 
 

  507,246,105  

 
 

 

 
 

  14,172  

 
 

 

 
 

  109  

 
 

 

 
 

  (374)  

 
 

 

 
 

  (17)  

 
 

 

 
 

  (391)  

 
 

 

 
 

  11,928  

 
 

 

 
 

  25,818  

 
 

 

 
 

  45  

 
 

 

 
 

  25,863  

 
 

Net earnings

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  571  

 
 

 

 
 

  571  

 
 

 

 
 

  5  

 
 

 

 
 

  576  

 
 

Other comprehensive income

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  1  

 
 

 

 
 

  1  

 
 

 

 
 

  2  

 
 

 

 
 

  

 
 

 

 
 

  2  

 
 

 

 
 

  

 
 

 

 
 

  2  

 
 

Shares repurchased (Note 9)

 
 

  (11,751,290)  

 
 

 

 
 

  (328)  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  (571)  

 
 

 

 
 

  (899)  

 
 

 

 
 

  

 
 

 

 
 

  (899)  

 
 

Dividends declared

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  (265)  

 
 

 

 
 

  (265)  

 
 

 

 
 

  

 
 

 

 
 

  (265)  

 
 

Non-controlling interest transactions

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  (6)  

 
 

 

 
 

  (6)  

 
 

Effect of share-based compensation including issuance of

 
                   
 

common shares

 
 

  579,208  

 
 

 

 
 

  34  

 
 

 

 
 

  (3)  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  31  

 
 

 

 
 

  

 
 

 

 
 

  31  

 
 

Transfer of net loss on cash flow hedges

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  5  

 
 

 

 
 

  5  

 
 

 

 
 

  

 
 

 

 
 

  5  

 
 

 

 
 

  

 
 

 

 
 

  5  

 
 

Transfer of net actuarial loss on defined benefit plans

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  3  

 
 

 

 
 

  3  

 
 

 

 
 

  (3)  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

Other

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  (2)  

 
 

 

 
 

  

 
 

 

 
 

  (2)  

 
 

 

 
 

  

 
 

 

 
 

  (2)  

 
 

 

 
 

  

 
 

 

 
 

  (2)  

 
 

  BALANCE – MARCH 31, 2023  

 
 

  496,074,023  

 
 

 

 
 

  13,878  

 
 

 

 
 

  106  

 
 

 

 
 

  (375)  

 
 

 

 
 

  (8)  

 
 

 

 
 

  (383)  

 
 

 

 
 

  11,660  

 
 

 

 
 

  25,261  

 
 

 

 
 

  44  

 
 

 

 
 

  25,305  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

(See Notes to the Condensed Consolidated Financial Statements)

 
 

  Condensed Consolidated Balance Sheets  

 
                                                                                                                                                                                                                                                                                                                                       
 

 

 
 

 

 
  

  March 31  

 
 

 

 
 

December 31

 
 

As at

 
 

Note

 
  

  2023  

 
 

 

 
 

2022

 
 

 

 
 

2022

 
 

  ASSETS  

 
 

 

 
  

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Current assets

 
 

 

 
  

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Cash and cash equivalents

 
 

 

 
  

  1,473  

 
 

 

 
 

577

 
 

 

 
 

901

 
 

Receivables

 
 

 

 
  

  6,009  

 
 

 

 
 

6,437

 
 

 

 
 

6,194

 
 

Inventories

 
 

 

 
  

  9,852  

 
 

 

 
 

9,068

 
 

 

 
 

7,632

 
 

Prepaid expenses and other current assets

 
 

 

 
  

  937  

 
 

 

 
 

943

 
 

 

 
 

1,615

 
 

 

 
 

 

 
  

  18,271  

 
 

 

 
 

17,025

 
 

 

 
 

16,342

 
 

Non-current assets

 
 

 

 
  

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Property, plant and equipment

 
 

 

 
  

  21,832  

 
 

 

 
 

19,998

 
 

 

 
 

21,767

 
 

Goodwill

 
 

 

 
  

  12,433  

 
 

 

 
 

12,287

 
 

 

 
 

12,368

 
 

Intangible assets

 
 

 

 
  

  2,292  

 
 

 

 
 

2,334

 
 

 

 
 

2,297

 
 

Investments

 
 

 

 
  

  686  

 
 

 

 
 

757

 
 

 

 
 

843

 
 

Other assets

 
 

 

 
  

  1,078  

 
 

 

 
 

867

 
 

 

 
 

969

 
 

  TOTAL ASSETS  

 
 

 

 
  

  56,592  

 
 

 

 
 

53,268

 
 

 

 
 

54,586

 
 

  LIABILITIES  

 
 

 

 
  

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Current liabilities

 
 

 

 
  

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Short-term debt

 
 

7

 
  

  4,013  

 
 

 

 
 

3,033

 
 

 

 
 

2,142

 
 

Current portion of long-term debt

 
 

 

 
  

  545  

 
 

 

 
 

551

 
 

 

 
 

542

 
 

Current portion of lease liabilities

 
 

 

 
  

  306  

 
 

 

 
 

293

 
 

 

 
 

305

 
 

Payables and accrued charges

 
 

 

 
  

  10,611  

 
 

 

 
 

11,013

 
 

 

 
 

11,291

 
 

 

 
 

 

 
  

  15,475  

 
 

 

 
 

14,890

 
 

 

 
 

14,280

 
 

Non-current liabilities

 
 

 

 
  

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Long-term debt

 
 

8

 
  

  9,510  

 
 

 

 
 

7,519

 
 

 

 
 

8,040

 
 

Lease liabilities

 
 

 

 
  

  880  

 
 

 

 
 

929

 
 

 

 
 

899

 
 

Deferred income tax liabilities

 
 

5

 
  

  3,603  

 
 

 

 
 

3,243

 
 

 

 
 

3,547

 
 

Pension and other post-retirement benefit liabilities

 
 

 

 
  

  242  

 
 

 

 
 

425

 
 

 

 
 

319

 
 

Asset retirement obligations and accrued environmental costs

 
 

 

 
  

  1,389  

 
 

 

 
 

1,523

 
 

 

 
 

1,403

 
 

Other non-current liabilities

 
 

 

 
  

  188  

 
 

 

 
 

208

 
 

 

 
 

235

 
 

  TOTAL LIABILITIES  

 
 

 

 
  

  31,287  

 
 

 

 
 

28,737

 
 

 

 
 

28,723

 
 

  SHAREHOLDERS' EQUITY  

 
 

 

 
  

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Share capital

 
 

9

 
  

  13,878  

 
 

 

 
 

15,398

 
 

 

 
 

14,172

 
 

Contributed surplus

 
 

 

 
  

  106  

 
 

 

 
 

133

 
 

 

 
 

109

 
 

Accumulated other comprehensive (loss) income

 
 

 

 
  

  (383)  

 
 

 

 
 

26

 
 

 

 
 

(391)

 
 

Retained earnings

 
 

 

 
  

  11,660  

 
 

 

 
 

8,931

 
 

 

 
 

11,928

 
 

Equity holders of Nutrien

 
 

 

 
  

  25,261  

 
 

 

 
 

24,488

 
 

 

 
 

25,818

 
 

Non-controlling interest

 
 

 

 
  

  44  

 
 

 

 
 

43

 
 

 

 
 

45

 
 

  TOTAL SHAREHOLDERS' EQUITY  

 
 

 

 
  

  25,305  

 
 

 

 
 

24,531

 
 

 

 
 

25,863

 
 

  TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY  

 
 

 

 
  

  56,592  

 
 

 

 
 

53,268

 
 

 

 
 

54,586

 
 

 

 
 

 

 
  

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

(See Notes to the Condensed Consolidated Financial Statements)

 
 

  Notes to the Condensed Consolidated Financial Statements  

 

  As at and for the Three Months Ended March 31, 2023  

 

  NOTE 1 BASIS OF PRESENTATION

 

Nutrien Ltd. (collectively with its subsidiaries, "Nutrien", "we", "us", "our" or "the Company") is the world's largest provider of crop inputs and services. Nutrien plays a critical role in helping growers around the globe increase food production in a sustainable manner.

 

These unaudited interim condensed consolidated financial statements ("interim financial statements") are based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, "Interim Financial Reporting". The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2022 annual consolidated financial statements. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual consolidated financial statements and should be read in conjunction with our 2022 annual consolidated financial statements.

 

Certain immaterial 2022 figures have been reclassified in the condensed consolidated statements of cash flows.

 

In management's opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year.

 

These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on May 10, 2023.

 

  NOTE 2 SEGMENT INFORMATION

 

The Company has four reportable operating segments: Nutrien Ag Solutions ("Retail"), Potash, Nitrogen and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and it provides services directly to growers through a network of farm centers in North America, South America and Australia. The Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each produces.

 
                                                                                                                                                                                                                                                                                                                             
 

 

 
 

 

 
 

  Three Months Ended March 31, 2023  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  Corporate  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  Retail  

 
 

 

 
 

  Potash  

 
 

 

 
 

  Nitrogen  

 
 

 

 
 

  Phosphate  

 
 

 

 
 

  and Others  

 
 

 

 
 

  Eliminations  

 
 

 

 
 

  Consolidated  

 
 

Sales

 
 

– third party

 
 

  3,422  

 
 

 

 
 

  1,023  

 
 

 

 
 

  1,154  

 
 

 

 
 

  508  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  6,107  

 
 

 

 
 

– intersegment

 
 

  

 
 

 

 
 

  54  

 
 

 

 
 

  264  

 
 

 

 
 

  64  

 
 

 

 
 

  

 
 

 

 
 

  (382)  

 
 

 

 
 

  

 
 

Sales

 
 

– total

 
 

  3,422  

 
 

 

 
 

  1,077  

 
 

 

 
 

  1,418  

 
 

 

 
 

  572  

 
 

 

 
 

  

 
 

 

 
 

  (382)  

 
 

 

 
 

  6,107  

 
 

Freight, transportation and distribution

 
 

  

 
 

 

 
 

  75  

 
 

 

 
 

  106  

 
 

 

 
 

  58  

 
 

 

 
 

  

 
 

 

 
 

  (40)  

 
 

 

 
 

  199  

 
 

Net sales

 
 

  3,422  

 
 

 

 
 

  1,002  

 
 

 

 
 

  1,312  

 
 

 

 
 

  514  

 
 

 

 
 

  

 
 

 

 
 

  (342)  

 
 

 

 
 

  5,908  

 
 

Cost of goods sold

 
 

  2,807  

 
 

 

 
 

  305  

 
 

 

 
 

  771  

 
 

 

 
 

  427  

 
 

 

 
 

  

 
 

 

 
 

  (315)  

 
 

 

 
 

  3,995  

 
 

Gross margin

 
 

  615  

 
 

 

 
 

  697  

 
 

 

 
 

  541  

 
 

 

 
 

  87  

 
 

 

 
 

  

 
 

 

 
 

  (27)  

 
 

 

 
 

  1,913  

 
 

Selling expenses

 
 

  765  

 
 

 

 
 

  3  

 
 

 

 
 

  8  

 
 

 

 
 

  2  

 
 

 

 
 

  (2)  

 
 

 

 
 

  (6)  

 
 

 

 
 

  770  

 
 

General and administrative expenses

 
 

  50  

 
 

 

 
 

  3  

 
 

 

 
 

  5  

 
 

 

 
 

  3  

 
 

 

 
 

  84  

 
 

 

 
 

  

 
 

 

 
 

  145  

 
 

Provincial mining taxes

 
 

  

 
 

 

 
 

  119  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  119  

 
 

Share-based compensation expense

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  15  

 
 

 

 
 

  

 
 

 

 
 

  15  

 
 

Other expenses (income)

 
 

  15  

 
 

 

 
 

  (7)  

 
 

 

 
 

  (14)  

 
 

 

 
 

  12  

 
 

 

 
 

  (81)  

 
 

 

 
 

  

 
 

 

 
 

  (75)  

 
 

(Loss) earnings before finance costs and income taxes

 
 

  (215)  

 
 

 

 
 

  579  

 
 

 

 
 

  542  

 
 

 

 
 

  70  

 
 

 

 
 

  (16)  

 
 

 

 
 

  (21)  

 
 

 

 
 

  939  

 
 

Depreciation and amortization

 
 

  181  

 
 

 

 
 

  97  

 
 

 

 
 

  134  

 
 

 

 
 

  67  

 
 

 

 
 

  17  

 
 

 

 
 

  

 
 

 

 
 

  496  

 
 

EBITDA 1

 
 

  (34)  

 
 

 

 
 

  676  

 
 

 

 
 

  676  

 
 

 

 
 

  137  

 
 

 

 
 

  1  

 
 

 

 
 

  (21)  

 
 

 

 
 

  1,435  

 
 

Integration and restructuring related costs

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  5  

 
 

 

 
 

  

 
 

 

 
 

  5  

 
 

Share-based compensation expense

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  15  

 
 

 

 
 

  

 
 

 

 
 

  15  

 
 

Foreign exchange gain, net of related derivatives

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

  (34)  

 
 

 

 
 

  

 
 

 

 
 

  (34)  

 
 

Adjusted EBITDA

 
 

  (34)  

 
 

 

 
 

  676  

 
 

 

 
 

  676  

 
 

 

 
 

  137  

 
 

 

 
 

  (13)  

 
 

 

 
 

  (21)  

 
 

 

 
 

  1,421  

 
 

Assets – at March 31, 2023

 
 

  25,858  

 
 

 

 
 

  13,526  

 
 

 

 
 

  11,673  

 
 

 

 
 

  2,658  

 
 

 

 
 

  3,589  

 
 

 

 
 

  (712)  

 
 

 

 
 

  56,592  

 
 

1 EBITDA is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

 
 
                                                                                                                                                                                                                                                                                                                                                        
 

 

 
 

 

 
 

Three Months Ended March 31, 2022

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Corporate

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Retail

 
 

 

 
 

Potash

 
 

 

 
 

Nitrogen

 
 

 

 
 

Phosphate

 
 

 

 
 

and Others

 
 

 

 
 

Eliminations

 
 

 

 
 

Consolidated

 
 

Sales

 
 

– third party

 
 

3,833

 
 

 

 
 

1,710

 
 

 

 
 

1,497

 
 

 

 
 

617

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

7,657

 
 

 

 
 

– intersegment

 
 

28

 
 

 

 
 

234

 
 

 

 
 

339

 
 

 

 
 

79

 
 

 

 
 

 
 

 

 
 

(680)

 
 

 

 
 

 
 

Sales

 
 

– total

 
 

3,861

 
 

 

 
 

1,944

 
 

 

 
 

1,836

 
 

 

 
 

696

 
 

 

 
 

 
 

 

 
 

(680)

 
 

 

 
 

7,657

 
 

Freight, transportation and distribution

 
 

 
 

 

 
 

94

 
 

 

 
 

95

 
 

 

 
 

61

 
 

 

 
 

 
 

 

 
 

(47)

 
 

 

 
 

203

 
 

Net sales

 
 

3,861

 
 

 

 
 

1,850

 
 

 

 
 

1,741

 
 

 

 
 

635

 
 

 

 
 

 
 

 

 
 

(633)

 
 

 

 
 

7,454

 
 

Cost of goods sold

 
 

3,016

 
 

 

 
 

305

 
 

 

 
 

881

 
 

 

 
 

428

 
 

 

 
 

 
 

 

 
 

(433)

 
 

 

 
 

4,197

 
 

Gross margin

 
 

845

 
 

 

 
 

1,545

 
 

 

 
 

860

 
 

 

 
 

207

 
 

 

 
 

 
 

 

 
 

(200)

 
 

 

 
 

3,257

 
 

Selling expenses

 
 

722

 
 

 

 
 

3

 
 

 

 
 

8

 
 

 

 
 

2

 
 

 

 
 

(2)

 
 

 

 
 

(6)

 
 

 

 
 

727

 
 

General and administrative expenses

 
 

45

 
 

 

 
 

2

 
 

 

 
 

6

 
 

 

 
 

3

 
 

 

 
 

70

 
 

 

 
 

 
 

 

 
 

126

 
 

Provincial mining taxes

 
 

 
 

 

 
 

249

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

249

 
 

Share-based compensation expense

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

135

 
 

 

 
 

 
 

 

 
 

135

 
 

Other (income) expenses

 
 

(12)

 
 

 

 
 

(3)

 
 

 

 
 

(26)

 
 

 

 
 

4

 
 

 

 
 

53

 
 

 

 
 

5

 
 

 

 
 

21

 
 

Earnings (loss) before finance costs and income taxes

 
 

90

 
 

 

 
 

1,294

 
 

 

 
 

872

 
 

 

 
 

198

 
 

 

 
 

(256)

 
 

 

 
 

(199)

 
 

 

 
 

1,999

 
 

Depreciation and amortization

 
 

169

 
 

 

 
 

112

 
 

 

 
 

123

 
 

 

 
 

41

 
 

 

 
 

16

 
 

 

 
 

 
 

 

 
 

461

 
 

EBITDA

 
 

259

 
 

 

 
 

1,406

 
 

 

 
 

995

 
 

 

 
 

239

 
 

 

 
 

(240)

 
 

 

 
 

(199)

 
 

 

 
 

2,460

 
 

Integration and restructuring related costs

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

9

 
 

 

 
 

 
 

 

 
 

9

 
 

Share-based compensation expense

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

135

 
 

 

 
 

 
 

 

 
 

135

 
 

COVID-19 related expenses

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

5

 
 

 

 
 

 
 

 

 
 

5

 
 

Foreign exchange loss, net of related derivatives

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

25

 
 

 

 
 

 
 

 

 
 

25

 
 

Gain on disposal of investment

 
 

(19)

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

(19)

 
 

Adjusted EBITDA

 
 

240

 
 

 

 
 

1,406

 
 

 

 
 

995

 
 

 

 
 

239

 
 

 

 
 

(66)

 
 

 

 
 

(199)

 
 

 

 
 

2,615

 
 

Assets – at December 31, 2022

 
 

24,451

 
 

 

 
 

13,921

 
 

 

 
 

11,807

 
 

 

 
 

2,661

 
 

 

 
 

2,622

 
 

 

 
 

(876)

 
 

 

 
 

54,586

 
 
                                                                                                                       
 

 

 
 

  Three Months Ended  

 
 

 

 
 

  March 31  

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

  Retail sales by product line  

 
 

 

 
 

 

 
 

 

 
 

Crop nutrients

 
 

  1,335  

 
 

 

 
 

1,587

 
 

Crop protection products

 
 

  1,154  

 
 

 

 
 

1,387

 
 

Seed

 
 

  507  

 
 

 

 
 

458

 
 

Merchandise

 
 

  246  

 
 

 

 
 

234

 
 

Nutrien Financial

 
 

  57  

 
 

 

 
 

49

 
 

Services and other

 
 

  148  

 
 

 

 
 

175

 
 

Nutrien Financial elimination 1

 
 

  (25)  

 
 

 

 
 

(29)

 
 

 

 
 

  3,422  

 
 

 

 
 

3,861

 
 

  Potash sales by geography  

 
 

 

 
 

 

 
 

 

 
 

Manufactured product

 
 

 

 
 

 

 
 

 

 
 

North America

 
 

  417  

 
 

 

 
 

927

 
 

Offshore 2

 
 

  660  

 
 

 

 
 

1,017

 
 

 

 
 

  1,077  

 
 

 

 
 

1,944

 
 

  Nitrogen sales by product line  

 
 

 

 
 

 

 
 

 

 
 

Manufactured product

 
 

 

 
 

 

 
 

 

 
 

Ammonia

 
 

  416  

 
 

 

 
 

591

 
 

Urea and ESN ® 3

 
 

  491  

 
 

 

 
 

540

 
 

Solutions, nitrates and sulfates

 
 

  371  

 
 

 

 
 

474

 
 

Other nitrogen and purchased products 3

 
 

  140  

 
 

 

 
 

231

 
 

 

 
 

  1,418  

 
 

 

 
 

1,836

 
 

  Phosphate sales by product line  

 
 

 

 
 

 

 
 

 

 
 

Manufactured product

 
 

 

 
 

 

 
 

 

 
 

Fertilizer

 
 

  302  

 
 

 

 
 

432

 
 

Industrial and feed

 
 

  195  

 
 

 

 
 

184

 
 

Other phosphate and purchased products

 
 

  75  

 
 

 

 
 

80

 
 

 

 
 

  572  

 
 

 

 
 

696

 
 

1 Represents elimination for the interest and service fees charged by Nutrien Financial to Retail branches.

 
 

2 Relates to Canpotex Limited ("Canpotex") (Note 11) and includes provisional pricing adjustments for the three months ended March 31, 2023 of $(147) (2022 – $62).

 
 

3 Certain immaterial 2022 figures have been reclassified.

 
 

  NOTE 3 SHARE-BASED COMPENSATION

 

The following table summarizes the awards granted under our existing share-based compensation plans described in Note 5 of our 2022 annual consolidated financial statements:

 
                         
 

 

 
 

  Three Months Ended  

 
 

 

 
 

  March 31  

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

Stock options:

 
 

 

 
 

 

 
 

 

 
 

Granted (number of units)

 
 

  301,168  

 
 

 

 
 

375,483

 
 

Weighted average grant date fair value (US dollars)

 
 

  25.67  

 
 

 

 
 

20.49

 
 

Cash-settled share-based awards granted (number of units) 1

 
 

  1,003,010  

 
 

 

 
 

970,461

 
 

1 For performance share units granted subsequent to January 1, 2022, return on invested capital over a three-year performance cycle is compared to Board-approved targets as an additional performance condition.

 
 

  NOTE 4 OTHER (INCOME) EXPENSES

 
                                                    
 

 

 
 

  Three Months Ended  

 
 

 

 
 

  March 31  

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

Integration and restructuring related costs

 
 

  5  

 
 

 

 
 

9

 
 

Foreign exchange (gain) loss, net of related derivatives

 
 

  (34)  

 
 

 

 
 

25

 
 

Earnings of equity-accounted investees

 
 

  (37)  

 
 

 

 
 

(41)

 
 

Bad debt expense

 
 

  9  

 
 

 

 
 

 
 

COVID-19 related expenses

 
 

  

 
 

 

 
 

5

 
 

Gain on disposal of investment

 
 

  

 
 

 

 
 

(19)

 
 

Project feasibility costs

 
 

  13  

 
 

 

 
 

12

 
 

Customer prepayment costs

 
 

  14  

 
 

 

 
 

13

 
 

Gain on amendments to other post-retirement pension plans

 
 

  (80)  

 
 

 

 
 

 
 

Other expenses

 
 

  35  

 
 

 

 
 

17

 
 

 

 
 

  (75)  

 
 

 

 
 

21

 
 

  NOTE 5 INCOME TAXES

 

A separate estimated average annual effective income tax rate was determined for each taxing jurisdiction and applied individually to the interim period pre-tax earnings for each jurisdiction.

 
                        
 

 

 
 

  Three Months Ended  

 
 

 

 
 

  March 31  

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

Income tax expense

 
 

  193  

 
 

 

 
 

505

 
 

Actual effective tax rate on earnings (%)

 
 

  23  

 
 

 

 
 

26

 
 

Actual effective tax rate including discrete items (%)

 
 

  25  

 
 

 

 
 

27

 
 

Discrete tax adjustments that impacted the tax rate

 
 

  18  

 
 

 

 
 

8

 
 

The following table summarizes the income tax balances within the condensed consolidated balance sheets:

 
                                                       
 

Income Tax Assets and Liabilities

 
 

Balance Sheet Location

 
 

  As at March 31, 2023  

 
 

 

 
 

As at December 31, 2022

 
 

Income tax assets

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Current

 
 

Receivables

 
 

  455  

 
 

 

 
 

144

 
 

Non-current

 
 

Other assets

 
 

  127  

 
 

 

 
 

54

 
 

Deferred income tax assets

 
 

Other assets

 
 

  487  

 
 

 

 
 

448

 
 

Total income tax assets

 
 

 

 
 

  1,069  

 
 

 

 
 

646

 
 

Income tax liabilities

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Current

 
 

Payables and accrued charges

 
 

  114  

 
 

 

 
 

899

 
 

Non-current

 
 

Other non-current liabilities

 
 

  48  

 
 

 

 
 

46

 
 

Deferred income tax liabilities

 
 

Deferred income tax liabilities

 
 

  3,603  

 
 

 

 
 

3,547

 
 

Total income tax liabilities

 
 

 

 
 

  3,765  

 
 

 

 
 

4,492

 
 

  NOTE 6 FINANCIAL INSTRUMENTS

 

   Fair Value   

 

Estimated fair values for financial instruments are designed to approximate amounts for which the instruments could be exchanged in a current arm's length transaction between knowledgeable, willing parties. The valuation policies and procedures for financial reporting purposes are determined by our finance department. There have been no changes to our valuation methods presented in Note 10 of the 2022 annual consolidated financial statements and those valuation methods have been applied in these interim financial statements.

 

The following table presents our fair value hierarchy for financial instruments carried at fair value on a recurring basis or measured at amortized cost and require fair value disclosure. The table does not include fair value information for financial instruments that are measured using their carrying amount as a reasonable approximation of fair value.

 
                                                                                                                                                                                                                                       
 

 

 
 

  March 31, 2023  

 
 

 

 
 

December 31, 2022

 
 

 

 
 

  Carrying  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Carrying

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  Financial assets (liabilities) measured at  

 
 

  Amount  

 
 

 

 
 

  Level 1  

 
 

 

 
 

  Level 2  

 
 

 

 
 

  Level 3  

 
 

 

 
 

Amount

 
 

 

 
 

Level 1

 
 

 

 
 

Level 2

 
 

 

 
 

Level 3

 
 

  Fair value on a recurring basis 1  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Derivative instrument assets

 
 

  7  

 
 

 

 
 

  

 
 

 

 
 

  7  

 
 

 

 
 

  

 
 

 

 
 

7

 
 

 

 
 

 
 

 

 
 

7

 
 

 

 
 

 
 

Other current financial assets - marketable securities 2

 
 

  155  

 
 

 

 
 

  29  

 
 

 

 
 

  126  

 
 

 

 
 

  

 
 

 

 
 

148

 
 

 

 
 

19

 
 

 

 
 

129

 
 

 

 
 

 
 

Investments at FVTOCI 3

 
 

  205  

 
 

 

 
 

  195  

 
 

 

 
 

  

 
 

 

 
 

  10  

 
 

 

 
 

200

 
 

 

 
 

190

 
 

 

 
 

 
 

 

 
 

10

 
 

Derivative instrument liabilities

 
 

  (26)  

 
 

 

 
 

  

 
 

 

 
 

  (26)  

 
 

 

 
 

  

 
 

 

 
 

(35)

 
 

 

 
 

 
 

 

 
 

(35)

 
 

 

 
 

 
 

  Amortized cost  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Current portion of long-term debt

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Notes and debentures

 
 

  (500)  

 
 

 

 
 

  (498)  

 
 

 

 
 

  

 
 

 

 
 

  

 
 

 

 
 

(500)

 
 

 

 
 

(493)

 
 

 

 
 

 
 

 

 
 

 
 

Fixed and floating rate debt

 
 

  (45)  

 
 

 

 
 

  

 
 

 

 
 

  (45)  

 
 

 

 
 

  

 
 

 

 
 

(42)

 
 

 

 
 

 
 

 

 
 

(42)

 
 

 

 
 

 
 

Long-term debt

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Notes and debentures

 
 

  (9,388)  

 
 

 

 
 

  (6,513)  

 
 

 

 
 

  (2,372)  

 
 

 

 
 

  

 
 

 

 
 

(7,910)

 
 

 

 
 

(3,581)

 
 

 

 
 

(3,656)

 
 

 

 
 

 
 

Fixed and floating rate debt

 
 

  (122)  

 
 

 

 
 

  

 
 

 

 
 

  (122)  

 
 

 

 
 

  

 
 

 

 
 

(130)

 
 

 

 
 

 
 

 

 
 

(130)

 
 

 

 
 

 
 

1 During the periods ended March 31, 2023 and December 31, 2022, there were no transfers between levels for financial instruments measured at fair value on a recurring basis.

 
 

2 Marketable securities consist of equity and fixed income securities.

 
 

3 Investments at fair value through other comprehensive income ("FVTOCI") is primarily comprised of shares in Sinofert Holdings Ltd.

 
 

  NOTE 7 SHORT-TERM DEBT

 
                                                                                                 
 

 

 
 

Rate of

 

Interest (%)

 
 

 

 
 

Total Facility Limit as at
March 31, 2023

 
 

 

 
 

  As at  

 

  March 31, 2023  

 
 

 

 
 

As at

 

December 31, 2022

 
 

Credit facilities

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Unsecured revolving term credit facility

 
 

n/a

 
 

 

 
 

4,500

 
 

 

 
 

  

 
 

 

 
 

  

 
 

Unsecured revolving term credit facility

 
 

5.9

 
 

 

 
 

2,000

 
 

 

 
 

  1,250  

 
 

 

 
 

  500  

 
 

Uncommitted revolving demand facility

 
 

n/a

 
 

 

 
 

1,000

 
 

 

 
 

  

 
 

 

 
 

  

 
 

Other credit facilities 1

 
 

 

 
 

 

 
 

1,240

 
 

 

 
 

 

 
 

 

 
 

 

 
 

South America

 
 

1.3 - 77.5

 
 

 

 
 

 

 
 

 

 
 

  484  

 
 

 

 
 

  453  

 
 

Australia

 
 

4.5

 
 

 

 
 

 

 
 

 

 
 

  147  

 
 

 

 
 

  190  

 
 

Other

 
 

0.8

 
 

 

 
 

 

 
 

 

 
 

  52  

 
 

 

 
 

  9  

 
 

Commercial paper

 
 

5.0 - 6.0

 
 

 

 
 

 

 
 

 

 
 

  1,905  

 
 

 

 
 

  783  

 
 

Other short-term debt

 
 

n/a

 
 

 

 
 

 

 
 

 

 
 

  175  

 
 

 

 
 

  207  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  4,013  

 
 

 

 
 

  2,142  

 
 

1 Total facility limit amounts include some facilities with maturities in excess of one year.

 
 

  NOTE 8 LONG-TERM DEBT

 
                        
 

  Issuance in the first quarter 2023  

 
 

  Rate of interest (%)  

 
 

 

 
 

  Maturity  

 
 

 

 
 

  Amount  

 
 

Notes issued 2023

 
 

4.900

 
 

 

 
 

March 27, 2028

 
 

 

 
 

  750  

 
 

Notes issued 2023

 
 

5.800

 
 

 

 
 

March 27, 2053

 
 

 

 
 

  750  

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  1,500  

 
 

The notes issued in the three months ended March 31, 2023 are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.

 

  NOTE 9 SHARE CAPITAL

 

   Share Repurchase Programs   

 
                                                             
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

  Maximum  

 
 

 

 
 

  Maximum  

 
 

 

 
 

  Number of  

 
 

 

 
 

  Commencement  

 
 

 

 
 

 

 
 

 

 
 

  Shares for  

 
 

 

 
 

  Shares for  

 
 

 

 
 

  Shares  

 
 

 

 
 

  Date  

 
 

 

 
 

  Expiry  

 
 

 

 
 

  Repurchase  

 
 

 

 
 

  Repurchase (%)  

 
 

 

 
 

  Repurchased  

 
 

2021 Normal Course Issuer Bid

 
 

March 1, 2021

 
 

 

 
 

February 28, 2022

 
 

 

 
 

28,468,448

 
 

 

 
 

5

 
 

 

 
 

22,186,395

 
 

2022 Normal Course Issuer Bid

 
 

March 1, 2022

 
 

 

 
 

February 7, 2023

 
 

 

 
 

55,111,110

 
 

 

 
 

10

 
 

 

 
 

55,111,110

 
 

2023 Normal Course Issuer Bid 1

 
 

March 1, 2023

 
 

 

 
 

February 29, 2024

 
 

 

 
 

24,962,194

 
 

 

 
 

5

 
 

 

 
 

3,748,498

 
 

1 The 2023 normal course issuer bid will expire earlier than the date above if we acquire the maximum number of common shares allowable or otherwise decide not to make any further repurchases.

 
 

Purchases under the normal course issuer bids were, or may be, made through open market purchases at market prices as well as by other means permitted by applicable securities laws, including private agreements.

 

The following table summarizes our share repurchase activities during the period:

 
                    
 

 

 
 

  Three Months Ended  

 
 

 

 
 

  March 31  

 
 

 

 
 

  2023  

 
 

 

 
 

2022

 
 

Number of common shares repurchased for cancellation

 
 

  11,751,290  

 
 

 

 
 

7,648,235

 
 

Average price per share (US dollars)

 
 

  76.57  

 
 

 

 
 

76.79

 
 

Total cost

 
 

  899  

 
 

 

 
 

587

 
 

   Dividends Declared   

 

We declared a dividend per share of $0.53 (2022 – $0.48) during the three months ended March 31, 2023, payable on April 13, 2023 to shareholders of record on March 31, 2023.

 

  NOTE 10 SEASONALITY

 

Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. The results of this seasonality have a corresponding effect on receivables from customers and rebates receivables, inventories, prepaid expenses and other current assets, and trade payables. Our short-term debt also fluctuates during the year to meet working capital needs. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

 

  NOTE 11 RELATED PARTY TRANSACTIONS

 

We sell potash outside Canada and the United States exclusively through Canpotex. Canpotex sells potash to buyers in export markets pursuant to term and spot contracts at agreed upon prices. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. Sales to Canpotex are shown in Note 2.

 
        
 

As at

 
 

  March 31, 2023  

 
 

 

 
 

December 31, 2022

 
 

Receivables from Canpotex

 
 

  528  

 
 

 

 
 

866

 
 

  NOTE 12 BUSINESS COMBINATIONS

 

On October 1, 2022, we acquired Casa do Adubo S.A. ("Casa do Adubo"). We have revised the total consideration paid for the acquisition to $277, net of cash and cash equivalents acquired, and amounts held in escrow, as a result of obtaining additional information and finalizing the purchase price agreement during the allowed measurement period, resulting in an increase to goodwill and intangible assets. Preliminary goodwill recognized on the Casa do Adubo acquisition was $177 as at March 31, 2023.

 

We have engaged independent valuation experts to assist in determining the fair value of certain assets acquired and liabilities assumed and related deferred income tax impacts. The valuation technique and judgments applied are consistent with those methods presented in Note 25 of the 2022 annual consolidated financial statements. As at March 31, 2023, the total consideration and purchase price allocation for Casa do Adubo is not final as we are continuing to obtain and verify information required to determine the fair value of certain assets acquired and liabilities assumed and the amount of deferred income taxes arising on their recognition. We will finalize the amounts recognized as we obtain the information necessary to complete the analysis within one year from the date of acquisition.

 

The following table allocates preliminary values to the acquired assets and assumed liabilities based upon fair values at their respective acquisition date:

 
                                                                                                                 
 

 

 
 

  March 31, 2023  

 
 

 

 
 

  Casa do Adubo  

 
 

 

 
 

  Preliminary at
December 31, 2022
 

 
 

 

 
 

  Adjustments  

 
 

   1  

 
 

  Revised Fair Value  

 
 

Receivables

 
 

174

 
 

 

 
 

(1)

 
 

 

 
 

  173  

 
 

Inventories

 
 

107

 
 

 

 
 

 
 

 

 
 

  107  

 
 

Prepaid expenses and other current assets

 
 

3

 
 

 

 
 

 
 

 

 
 

  3  

 
 

Property, plant and equipment

 
 

24

 
 

 

 
 

 
 

 

 
 

  24  

 
 

Goodwill

 
 

145

 
 

 

 
 

32

 
 

 

 
 

  177  

 
 

Intangible assets

 
 

95

 
 

 

 
 

8

 
 

 

 
 

  103  

 
 

Other non-current assets

 
 

6

 
 

 

 
 

 
 

 

 
 

  6  

 
 

Total assets

 
 

554

 
 

 

 
 

39

 
 

 

 
 

  593  

 
 

Short-term debt

 
 

14

 
 

 

 
 

 
 

 

 
 

  14  

 
 

Payables and accrued charges

 
 

159

 
 

 

 
 

 
 

 

 
 

  159  

 
 

Long-term debt, including current portion

 
 

91

 
 

 

 
 

 
 

 

 
 

  91  

 
 

Lease liabilities, including current portion

 
 

10

 
 

 

 
 

 
 

 

 
 

  10  

 
 

Other non-current liabilities

 
 

1

 
 

 

 
 

 
 

 

 
 

  1  

 
 

Total liabilities

 
 

275

 
 

 

 
 

 
 

 

 
 

  275  

 
 

Total consideration, net of cash and cash equivalents acquired

 
 

279

 
 

 

 
 

39

 
 

 

 
 

  318  

 
 

Amounts held in escrow

 
 

(48)

 
 

 

 
 

7

 
 

 

 
 

  (41)  

 
 

Total consideration, net of cash and cash equivalents acquired, and amounts held in escrow

 
 

231

 
 

 

 
 

46

 
 

 

 
 

  277  

 
 

1 We recorded adjustments to the preliminary fair value to reflect facts and circumstances in existence as of the date of acquisition. These adjustments primarily relate to changes in the preliminary valuation assumptions, including refinement of intangible assets. All measurement period adjustments were offset against goodwill.

 
 

 

 

  

  

  Investor Relations:  
Jeff Holzman
Vice President, Investor Relations
(306) 933-8545
Investors@nutrien.com  

Media Relations:  
Megan Fielding
Vice President, Brand & Culture Communications
(403) 797-3015

 

News Provided by Business Wire via QuoteMedia

NTR:CA,NTR
The Conversation (0)

Nutrien Announces Ken Seitz and Jeff Tarsi as Speakers at the BofA Investor Conference

 

 Nutrien Ltd. (TSX and NYSE: NTR) announced today that Mr. Ken Seitz, Nutrien's President and Chief Executive Officer, and Mr. Jeff Tarsi, Nutrien's Executive Vice President and President, Global Retail, will be speaking at the 2025 BofA Global Agriculture and Materials Conference on Wednesday, February 26 at 10:30am EST.

 

The fireside chat will be video cast and available on the Company's website at https://www.nutrien.com/investors/events  

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Combine harvester harvests ripe wheat.

Top 10 Phosphate Countries by Production

Phosphate is mainly used in the form of fertilizer for crops and animal feed supplements. Only 5 percent of world phosphate production is used for other applications, such as corrosion prevention and detergents.

Demand for phosphate fertilizers had created a US$54.6 billion market by 2023, and that figure is expected to grow at a compound annual growth rate of 5.3 percent through 2030 to reach US$78.4 billion.

"One of the primary factors influencing the worldwide market for phosphate fertilizers is the increasing focus on sustainable agriculture," according to Persistence Market Research. "Phosphate fertilizers, which are widely recognized for their ability to augment soil fertility and enhance crop productivity, are crucial for the pursuit of sustainability objectives in the agricultural industry."

Keep reading...Show less
Tractor on farm field.

9 Phosphate Stocks to Watch

Demand for both phosphate and potash fertilizers is anticipated to continue growing as the world’s population increases and the amount of arable land decreases.

The phosphate market is expected to witness a compound annual growth rate of 5.3 percent between 2023 and 2030 to reach US$78.4 billion. Driving this growth will be increasing pressure on global food supply brought on by rising populations and climate change, as well as inflation and downstream costs. Phosphate is also increasingly becoming a sought-after battery material for the electric vehicle industry due to its use in lithium-iron-phosphate (LFP) batteries.

Thankfully, phosphate-mining production around the globe is expected to increase, with the largest areas of growth being Africa and the Middle East. Phosphate mining companies with project developments in Brazil, Kazakhstan, Mexico, Peru and Russia are all expected to contribute to increased phosphate rock production as well.

Keep reading...Show less
Hands holding coins with a sprout growing out of them.

How to Invest in Phosphate (Updated 2024)

Discovering ways to invest in phosphate begins with understanding its primary uses.

Notably, about 90 percent of phosphate is consumed by the agriculture sector. Because of its essential properties, and since there is no known substitute for it, phosphate can be found in fertilizer products all over the world as a way to aid plant growth. It is also used as a supplement in animal feed, as a food preservative and for several other chemical purposes.

As the world's population grows and demand for food increases, the need for phosphate fertilizer is only expected to increase. For that reason, some believe phosphate investing is compelling. Read on for a brief overview of the phosphate market, including supply and demand dynamics and investing options.

Keep reading...Show less
farm crops in a field

5 Top Weekly TSXV Stocks: Arianne Phosphate Grows with Nearly 80 Percent Gain

The S&P/TSX Venture Composite Index (INDEXTSI:JX) dropped 1.1 points this past week to close at 551.23.

The Bank of Canada held steady, announcing on Wednesday (January 24) that it will be maintaining a 5 percent target for its key overnight rate. It based its decision on year-end inflation figures that peg inflation at 3.4 percent for December.

The central bank expects inflation to remain in the 3 percent range for the first six months of 2024, before easing toward its 2 percent target in 2025. Meanwhile, the Bank of Canada projects that the country's gross domestic product (GDP) will remain relatively flat in 2024; it is projecting a 0.8 percent increase for the year, with a 2.4 percent increase in 2025.

Keep reading...Show less
vegetable plantation

Understanding Raw Rock Phosphate: What Investors Need to Know

Phosphate is an essential component in global food production, with nearly 90 percent of all production going to the agriculture sector.

In addition to being a core ingredient in much of the world's fertilizer, the mineral is also used as a food preservative, to supplement animal feed and in products such as lithium iron phosphate batteries.

As the world's population continues to grow, demand for phosphate will only increase. While this trend can make phosphate a very attractive investment, it is not something one should dive into without research.

Keep reading...Show less

Latest Press Releases

Related News

×